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ABSTRACT 
 
 
Kv1.2 is a member of the Shaker family of voltage-sensitive potassium channels 
and contributes to regulation of membrane excitability.  The electrophysiological activity 
of Kv1.2 undergoes tyrosine kinase-dependent suppression in a process involving RhoA.  
We report that RhoA elicits suppression of Kv1.2 ionic current by modulating channel 
endocytosis.  This occurs through two distinct pathways, one clathrin-dependent and the 
other cholesterol-dependent.  Activation of RhoA downstream effectors Rho-kinase 
(ROCK) or protein kinase N (PKN) via the lysophosphatidic acid (LPA) receptor elicits 
clathrin-dependent Kv1.2 endocytosis and consequent attenuation of its ionic current.  
LPA-induced channel endocytosis is blocked by ROCK inhibition , dominant negative 
PKN, or by clathrin RNAi.  In contrast, steady-state endocytosis of Kv1.2 in un-
stimulated cells is cholesterol-dependent.  Inhibition of basal ROCK with Y27632 or 
basal PKN with HA1077 increases steady-state surface Kv1.2.  The Y27632-induced 
increase persists in the presence of clathrin RNAi and, in the presence of the sterol-
binding agent filipin, does not elicit an additive effect.  Temperature block experiments in 
conjunction with studies that perturb trafficking of newly synthesized proteins from the 
Golgi demonstrate that basal ROCK affects cholesterol-dependent trafficking by 
modulating the recycling of constitutively endocytosed Kv1.2 back to the plasma 
membrane.  Both receptor-stimulated and steady-state Kv1.2 trafficking modulated by 
RhoA/ROCK require the activation of dynamin as well as the ROCK effector LIM 
kinase, indicating a key role for actin remodeling in RhoA-dependent Kv1.2 regulation.  
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GLOSSARY 
 
 
α-CHCm: Mouse monoclonal antibody that recognizes the heavy chain of clathrin 
α-EEA1m: Mouse monoclonal antibody that recognizes the early endosome marker  
     EEA1 
α-Kv1.2e: Rabbit polyclonal antibody that recognizes the first extracellular loop of  
     Kv1.2 
α-pMYPT1p: Rabbit polyclonal antibody that recognizes Thr696 phosphorylated   
     myosin phosphatase target subunit 1 
α-RhoAm: Rat monoclonal antibody that recognizes total RhoA 
BFA: Brefeldin A 
CCh: Carbachol 
DMSO: Dimethyl sulfoxide 
EEA1: Early endosome antigen 1 
GAP: GTPase activating protein 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase 
GDI: Guanine nucleotide dissociation inhibitor 
GDP: Guanosine di-phosphate 
GEF: Guanine nucleotide exchange factor 
GM130: Golgi matrix protein of 130 kD 
GTP: Guanosine tri-phosphate 
HA1077: Protein kinase N inhibitor 
HEK-K: Human embryonic kidney 293 cells stably expressing the m1 acetylcholine  
     receptor, Kv1.2α, and Kvβ2. 
LIMK: LIM kinase 
LPA: Lysophosphatidic acid 
MeOH: Methanol 
NT: Non-targeting 
pMYPT1: Myosin phosphatase target subunit 1 
PKN: Protein kinase N 
RNAi: Ribonucleic acid interference 
ROCK: Rho-kinase 
SRE: Serum response element 
Y27632: Rho-kinase inhibitor 
 
 
 
 
 
 
CHAPTER 1: LITERATURE REVIEW 
 
 Potassium Channels 
Regulation of cellular excitability and resting membrane potential is important in 
many different cell types and critical for processes such as neurotransmission, 
cardiovascular regulation, and learning and memory.  This regulation is accomplished by 
the combined contribution of many different ion channels.  Among these, potassium 
channels are an important participant.   
Excitable cells are set up with a high concentration of potassium in the cytoplasm, 
such that when potassium channels open, positively charged ions flow out of the cell, 
down their concentration gradient (Figure 1) (Kandel et al., 2000).  The end result is a 
reduction of positive charge inside the cell, making the membrane potential more 
negative, thus the cell becomes less excitable, or hyperpolarized (Kandel et al., 2000).    
All potassium channels are comprised of multiple alpha subunits that make up the 
pore-forming portion of the channel.  These alpha subunits can contain varying numbers 
of trans-membrane domains, depending on the channel type, along with cytoplasmic N 
and C termini.  Intracelluar beta subunits interact with the hydrophilic alpha subunit N-
terminus (Rhodes et al., 1995; Jan and Jan, 1997) and can modulate channel kinetics and 
trafficking (Shi et al., 1996; Shi and Trimmer, 1999; Wissmann et al., 1999; Long et al., 
2005).  When functioning properly, potassium channels have a flow rate that approaches 
1x108 ions  sec-1 (Grottesi et al., 2005). 
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All potassium channels have a highly conserved selectivity filter that allows only 
potassium ions to flow through the pore (MacKinnon, 1995).  This filter is comprised of 
extracellular loops from the alpha subunits, P-loops, dipping into the plasma membrane 
(MacKinnon, 2003).  In order for potassium ions to flow through the channel, they must 
first be dehydrated, creating an energetic barrier for ion flow.  Channels overcome this 
barrier by lining the interior of the filter with carbonyl oxygens that interact with 
potassium ions, mimicking hydration (Figure 2) (Doyle et al., 1998; Choe, 2002).  Other 
positively charged cations, like sodium, have different atomic radii than potassium and 
cannot effectively interact with the carbonyl oxygens lining the filter (MacKinnon, 2003).   
There are four interaction sites for potassium ions within the filter (S1-S4) and 
two exterior sites, one on each side of the pore (Choe, 2002).  Only two internal sites are 
occupied at any one time, S1 and S3 or S2 and S4.  As such there is concerted ion flow 
through the filter with repulsive forces between positively charged ions aiding the flow of 
potassium (Berneche and Roux, 2001; Morais-Cabral et al., 2001; MacKinnon, 2003).  In 
addition, it has been reported that the selectivity filter transitions between two 
conformation states depending upon interaction with potassium.  When potassium is 
present, channels adopt a conductive conformation with sites S1 thru S4 available for 
interaction.  When potassium is not present, channels adopt a non-conductive 
conformation with sites S2 and S3 pinched shut to prevent ion flow (Valiyaveetil et al., 
2006).  Potassium channels therefore have two levels of ion selectivity. 
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Kv1.2 Overview 
Several types of potassium channel exist.  Of particular importance to the 
regulation of membrane potential and cellular excitability are the Shaker family voltage-
sensitive potassium channels, of which Kv1.2 is a member.  Other Shaker family 
channels include Kv1.1, 1.3, 1.4, 1.5, and 1.6 (Chandy, 1991; Roberds and Tamkun, 
1991).  These channels were originally isolated from Drosophila during studies of the 
Shaker gene (Kamb et al., 1987; Solc et al., 1987).  Kv1.2 can be found in hippocampal 
and cerebellar neurons (Tsaur et al., 1992; Sheng et al., 1994; Veh et al., 1995; Grosse et 
al., 2000), vascular smooth muscle (Adda et al., 1996; Wang et al., 1997; Wang et al., 
2005), and cardiac muscle (Cox et al., 2001; Hong et al., 2004) where it functions as a 
delayed rectifier.  Kv1.2 regulates diverse physiological functions, including the 
maintenance of action potential proliferation along myelinated axons (Rasband et al., 
2001; Rasband and Trimmer, 2001; Rasband, 2004),  transduction of pain in peripheral 
sensory neurons (Ishikawa et al., 1999; Kim et al., 2002; Yang et al., 2004) and 
modulation of tone in vascular smooth muscle cells (Adda et al., 1996; Wang et al., 
1997; Wang et al., 2005).  Dysregulation of Kv1.2 has been implicated in disease states 
such as hypertension (Cox et al., 2001; Hong et al., 2004), neuropathic pain (Ishikawa et 
al., 1999; Kim et al., 2002; Yang et al., 2004) and seizure activity in the central nervous 
system (Lambe and Aghajanian, 2001; Brew et al., 2007).  These are all loss-of-function  
phenotypes. 
Kv channels are comprised of 4 alpha and 4 beta subunits.  Each alpha subunit has 
six trans-membrane domains (S1-S6 helices).  The tetramer forms a single pore (Papazian 
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et al., 1991; Papazian et al., 1995; Seoh et al., 1996).  The P-loop occurs between helices 
S5 and S6.  The N and C-terminus of the alpha subunit are cytoplasmic, with the N-
terminus containing a tetramerization (T1) domain (Choe, 2002) which interacts with the 
beta subunit (Rhodes et al., 1995; Jan and Jan, 1997).  Kv1.2 is most commonly 
associated with the Kv beta 2 subunit (Shi et al., 1996).  The S4 helix acts as the voltage 
sensor.  It contains four positively charged arginines at positions 294, 297, 300, and 303 
that allow the helix to move in relation to the rest of the channel when voltage across the 
plasma membrane changes.  Movement of the S4 helix allows the pore region of the 
channel to open or close (Long et al., 2005) (Figure 3). 
 
Kv1.2 Regulation 
Kv1.2 is regulated by a diverse array of signals.  It was the first potassium 
channel for which tyrosine phosphorylation was demonstrated to control activity (Pearson 
and Kemp, 1991; Huang et al., 1993).  Phosphorylation of tyrosine 132 results in 
suppression of Kv1.2 ionic current.  This occurs in response to stimulation of the M1 
muscarinic acetylcholine receptor (M1 mAChR) with carbachol (CCh) in both Xenopus 
oocytes and human embryonic kidney 293 (HEK-K) over-expression systems (Huang et 
al., 1993).  Kv1.3 and Kv1.5 can be tyrosine phosphorylated, also resulting in ionic 
current suppression (Lev et al., 1995; Holmes et al., 1996; Fadool et al., 1997; Mason et 
al., 2002).  Alternatively, threonine phosphorylation of Kv1.2 by protein kinase A (PKA) 
at position 46 also occurs, resulting in enhanced ionic current (Huang et al., 1994). 
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 Phosphorylation is catalyzed by enzymes called kinases that specifically transfer 
the γ terminal phosphate from ATP to the hydroxyl group of a particular serine, 
threonine, or tyrosine of the target protein (Alberts et al., 2002).  The addition of a 
phosphate group, which contains four oxygen atoms, allows for complex hydrogen 
bonding to occur between different, sometimes distant, amino acids in the protein.  This, 
coupled with the fact that the phosphate group has two negative charges at physiological 
pH, allows for significant conformational changes of the protein structure to occur 
(Johnson and O'Reilly, 1996). 
One common structural change that occurs upon protein phosphorylation is 
hydrogen bonding between the phosphate group oxygens with nitrogens of the peptide 
backbone at the start of protein alpha-helical regions.  There tends to be more glycine 
residues at these locations, whose lack of a bulky side chain allows for tight hydrogen 
bonds to form (Hol, 1985; Chakrabarti, 1993; Copley and Barton, 1994).  Another 
common structural change occurs when the negatively charged phosphate group interacts 
with the positively charged side chain of an arginine residue, a tight electrostatic 
interaction (Chakrabarti, 1993; Copley and Barton, 1994).  Both types of phosphate 
group binding result in significant structural changes to the phosphorylated proteins 
compared to their non-phosphorylated counterparts, which in turn can affect the 
activation or inhibition of protein function or the protein-protein interactions that occur 
(Johnson and O'Reilly, 1996).  It is not clear whether any conformational changes to the 
channel occur following Kv1.2 phosphorylation, but phosphorylation of Kv1.2 regulatory 
proteins can be crucial for channel function. 
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Kv1.2 trafficking has emerged as a key mechanism for regulating channel 
activity.  Following CCh stimulation, Kv1.2 is internalized to early endosomes.  This 
process is dynamin-dependent and requires an intact actin cytoskeleton.  Alterations to 
the channel that prevent tyrosine phosphorylation-dependent ionic current suppression 
also prevent Kv1.2 endocytosis (Nesti et al., 2004).  Further research has demonstrated 
that the cyclic-AMP (cAMP) pathway regulates the level of Kv1.2 on the cell surface in 
both PKA-dependent and independent manners.  Basal levels of cAMP modulate steady-
state homeostasis of the channel through PKA signaling.  Increasing cAMP levels by 
application of the adenylate cyclase activator forskolin, increases Kv1.2 at the cell 
surface by negatively regulating homeostatic turnover of the channel in a PKA-
independent manner.  Essential for the cAMP-mediated effects is dynamin and the actin-
regulating protein cortactin (Connors et al., 2008).  Cortactin is an actin-binding protein 
known to activate the Arp2/3 complex, leading to actin filament branching and dynamic 
cytoskeletal structure formation (Wu and Parsons, 1993; Huang et al., 1997).  Other 
studies have demonstrated a direct interaction between Kv1.2 and cortactin that is 
reduced upon channel tyrosine phosphorylation.  The interaction is prevalent at the edge 
of cells, while their interaction is significantly reduced under conditions that favor Kv1.2 
endocytosis (Hattan et al., 2002; Williams et al., 2007).  Cortactin binds the Kv1.2 C-
terminus between positions 445 and 463.  An intact cortactin C-terminus is also essential 
because it contains specific tyrosines that are important for proper channel trafficking.  
These tyrosines in the C-terminus of cortactin are also potential targets of Src kinase and 
may serve a scaffolding function to recruit other cytoskeletal proteins or components of 
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the endocytosis machinery.  Mutations that abolish the ability of cortactin to bind F-actin 
or activate the Arp2/3 complex reduce steady-state levels of surface Kv1.2 or the ability 
of CCh to suppress Kv1.2 respectively (Williams et al., 2007). 
This is not the first evidence implicating the actin cytoskeleton as an important 
player in the regulation of Kv1.2.  Previously, it was also demonstrated that RhoA, 
another actin-modulating protein, could affect Kv1.2 function (Cachero et al., 1998).  As 
evidenced by two-hybrid screen analysis, RhoA interacts with Kv1.2 requiring an intact 
channel N-terminus.  Over-expression of RhoA suppresses Kv1.2 ionic current while 
pharmacological inhibition of RhoA enhances Kv1.2 ionic current.  These effects are 
specific to RhoA, as over-expression of other Rho GTPases do not alter Kv1.2 ionic 
current (Cachero et al., 1998).  Evidence suggests that RhoA functions as part of the 
tyrosine phosphorylation-dependent suppression pathway.  Mutation of tyrosine 132, 
required for tyrosine phosphorylation-dependent Kv1.2 suppression, significantly 
diminishes the ability of RhoA to reduce channel currents.  Furthermore, inhibition of 
RhoA with C3 exoenzyme can prevent CCh-induced Kv1.2 current suppression (Cachero 
et al., 1998).  Little is known, however, about the mechanism of Kv1.2 suppression 
downstream of RhoA. 
 
Rho GTPases 
RhoA is member of the Rho GTPase family of actin-regulating proteins which are 
members of the larger Ras superfamily of monomeric, 20-30 kilo dalton GTP-binding 
proteins.  In mammals the Ras superfamily is comprised of five major groups, those 
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being Ras, Rho, Rab, Arf, and Ran proteins (Etienne-Manneville and Hall, 2002).  There 
are twenty genes that encode the Rho GTPases which can be further broken down into 
smaller classes, those being Rho, Rac, Cdc42, Rnd, RhoD, and TTF (Hall, 1998; 
Aspenstrom, 1999).  These proteins undergo dynamic cycling between GDP and GTP-
bound states.  When GTP-bound, Rho GTPases are active and can regulate various 
cytoskeletal structures within the cell or certain signaling pathways.  Most Rho GTPases 
also have a geranyl-geranyl post-translational modification on their C-terminus which 
allows them to associate with cellular membranes (Adamson et al., 1992; Cox and Der, 
1992; Seabra, 1998).  These proteins have demonstrated, critical roles for processes such 
as cytokinesis, phagocytosis, pinocytosis, cell migration, cell morphogenesis, and axon 
guidance.  Rho GTPases have also been shown to regulate Serum Response Factor 
(SRF), JNK/p-38 MAP Kinase, NADPH oxidase, and cell cycle progression signaling 
pathways (Ridley and Hall, 1992; Cox et al., 1997; Drechsel et al., 1997; Luo et al., 
1997; Nobes and Hall, 1999; Settleman, 1999; Prokopenko et al., 2000).  Clearly, Rho 
GTPases are important regulators of cellular function. 
 Because of their involvement in so many critical processes, tight regulation of 
Rho GTPase activity is necessary.  Guanine nucleotide cycling and cellular localization 
of the GTPases is regulated by the combined activity of three sets of proteins known as 
GEFs, GAPs, and GDIs (Kjoller and Hall, 1999) (Figure 4).  GEFs, or guanine 
nucleotide exchange factors, catalyze the exchange of bound GDP for GTP.  All GEFs 
contain a catalytic Dbl-homology (DH) domain responsible for nucleotide exchange as 
well as an adjacent pleckstrin-homology (PH) domain which can modulate the 
 8
interaction of the GEF with membranes (Hart et al., 1994; Zheng et al., 1996; Rameh et 
al., 1997; Cherfils and Chardin, 1999).  GAPs, or GTPase activating proteins, enhance 
the intrinsic GTPase activity of the Rho protein.  GAPs function by insertion of an 
arginine finger motif into the active site of the GTPase which stabilizes a molecular 
transition state during the hydrolysis of GTP to GDP, thus speeding up the reaction 
(Lamarche and Hall, 1994; Rittinger et al., 1997a; Rittinger et al., 1997b).  GDIs, or 
guanine nucleotide dissociation inhibitors, prevent the exchange of GDP for GTP and 
can sequester Rho GTPases in the cytoplasm of the cell (Olofsson, 1999).  GDIs have 
an immunoglobulin-like, hydrophobic pocket on their C-terminus which can bind and 
mask the geranyl-geranylation of Rho GTPases, making them soluble, while their N-
terminus interacts with the GTPase, preventing nucleotide exhange (Gosser et al., 1997; 
Keep et al., 1997; Longenecker et al., 1999; Olofsson, 1999; Hoffman et al., 2000).  
There are currently over sixty known GEFs and 70 known GAPs for Rho GTPases 
(Etienne-Mannville 2002).  Clearly, Rho GTPases are subject to tight regulation. 
 
RhoA Overview 
RhoA is involved in a large array of important cellular processes.  By virtue of 
its ability to signal through many different downstream effectors, RhoA signaling is an 
important initiating upstream event (Figure 5).  To activate RhoA it must bind GTP, 
which results in a conformational change of the protein.  This conformational change 
occurs primarily in regions of the GTPase known as switch I and switch II (amino acids 
28-44 and 62-69 in human RhoA respectively) (Ihara et al., 1998).  When bound to GTP, 
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hydrogen bonds within the switch regions occur to stabilize the conformational change. 
(Wei et al., 1997; Rudolph et al., 1999).  Switch I and II regions are also areas of contact 
between RhoA and downstream effectors such as Rho-kinase (ROCK) and protein kinase 
N (PKN).  In general, these effectors interact directly with RhoA via anti-parallel coiled 
coil (ACC) finger folds at these sites (Flynn et al., 1998; Maesaki et al., 1999; Zong et 
al., 1999; Bishop and Hall, 2000).  Interaction with RhoA leads to effector activation, 
typically by relieving intra-molecular auto-inhibition (Bishop and Hall, 2000). 
 In order for RhoA to interact with downstream effectors though, RhoA itself 
must first become activated and it is widely accepted that activation of RhoA occurs 
through signaling of G protein-coupled receptors.  Interestingly, it has been shown that 
stimulation of the M1 muscarinic acetylcholine receptor (M1 mAChR) with CCh leads to 
RhoA activation via Gαq through an EGF receptor-dependent pathway (Kjoller and Hall, 
1999; Hilal-Dandan et al., 2004; Nishida et al., 2005; Riobo and Manning, 2005).  This 
pathway has previously been implicated in the tyrosine kinase-dependent suppression of 
Kv1.2 ionic current (Huang et al., 1993).  Another critical means of RhoA activation is 
through G protein-coupled receptors that signal through G12/13.  Specific pharmacological 
agents known to stimulate G12/13 include lysophosphatidic acid (LPA), thrombin, 
bombesin, sphingosine-1-phosphate (S-1-P) and endothelin, which results in recruitment 
of p115 RhoGEF and subsequent GTP loading of RhoA (Hart et al., 1998; Kozasa et al., 
1998; Kjoller and Hall, 1999).  Activation of RhoA results in more of the protein 
becoming membrane-bound by virtue of C-terminal geranyl-geranylation unmasking as 
interactions with Rho-GDIs are reduced (Fleming et al., 1996; Donovan et al., 1997; 
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Gong et al., 1997; Aoki et al., 1998; Seasholtz et al., 1999).  In fact, CCh stimulation of 
M1 mAChR has been shown to reduce cytosolic and increase membrane-bound RhoA in 
HEK293 cells in the presence of GTPγS (Keller et al., 1997).   
  RhoA activity has been shown to affect many different cellular processes, some 
examples of which will be given below.  This speaks to the significant contribution of 
RhoA signaling to the normal functioning of our cells.  Initial studies of RhoA in Swiss 
3T3 fibroblasts primarily demonstrated its ability to modulate the cytoskeleton, such as 
induction of stress fiber formation, focal adhesion complex formation, cellular 
contraction, and actin-myosin interaction through ROCK (Paterson et al., 1990; Ridley 
and Hall, 1992; Noda et al., 1995; Amano et al., 1996a; Kimura et al., 1996).  
Subsequent studies have shown activity of RhoA and its effectors do much more.  For 
example, LPA-induced RhoA activity is necessary for proper NF-κB transcription factor 
activity in 3T3 and COS-7 cells. (Pan et al., 1996; Perona et al., 1997; Pan et al., 1998; 
Shahrestanifar et al., 1999).  Additionally, RhoA downstream effectors ROCK and PKN 
have been shown to activate serum response element (SRE)-mediated gene transcription 
(Quilliam et al., 1996; Chihara et al., 1997; Sahai et al., 1998).  RhoA activity also plays 
a key role in processes such as normal cellular migration and for invasion of tumor cells 
as evidenced by unsuccessful scrape-wound closure of NRK49F fibroblasts in the 
presence of dominant negative ROCK, the prevention of chemotactic neutrophil 
migration in the presence of the ROCK inhibitor Y27632, and the ability of LPA 
stimulation to elicit cell monolayer penetration by rat hepatoma cells (Imamura et al., 
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1993; Fukata et al., 1999; Niggli, 1999).  Clearly, appropriate signaling of RhoA and its 
effectors is very important and, when perturbed, can have profound cellular effects. 
 Another important example of how RhoA signaling can have profound effects is 
one in which regulation and function of Kv1.2 is also paramount.  It has been shown that 
RhoA and ROCK expression and activity are enhanced in cardiac myocytes and vascular 
smooth muscle cells in disease states such as hypertension.  (Kobayashi et al., 2002; 
Satoh et al., 2003; Torsoni et al., 2003; Hattori et al., 2004).  ROCK phosphorylates and 
inhibits the action of myosin light chain phosphatase, resulting in higher levels of myosin 
light chain phosphorylation, increased myosin filament contraction, and hypertension. 
(Noda et al., 1995; Kimura et al., 1996).  In fact, treatment with the ROCK inhibitor 
Y27632 has been shown to lower blood pressure (Uehata et al., 1997; Seasholtz et al., 
2001; Seko et al., 2003; Moriki et al., 2004).  It is also known that in a rat model of 
hypertension, vascular smooth muscle cells have increased levels of calcium influx and 
higher intracellular calcium concentrations which have been shown to suppress the 
function of the voltage-sensitive potassium channel Kv1.2 (Lozinskaya and Cox, 1997).  
As stated previously, it is known that RhoA signaling itself can modulate the function of 
Kv1.2 (Cachero et al., 1998).  It appears, therefore, that the potential exists for RhoA 
signaling to perform dual roles in the context of the cardiovascular system by controlling 
smooth muscle constriction and ion channel function simultaneously. 
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 Rationale 
The mechanism by which RhoA modulates Kv1.2 function is not yet known, but 
trafficking of the channel has emerged as an important method for its regulation.  This 
study examines the contribution of RhoA and its effectors to the well-established 
endocytosis-based regulation of Kv1.2.  RhoA can exert its effects through direct protein-
protein interaction or through downstream effectors.  Rho-kinase (ROCK) is perhaps the 
most well understood downstream effector of RhoA and therefore received the most 
attention, however we do investigate the role of protein kinase N (PKN) as well.  ROCK 
is a serine/threonine kinase whose activity is enhanced by interacting with active RhoA 
(Ishizaki et al., 1996; Matsui et al., 1996).  ROCK is responsible for modulating many 
actin-based processes in cells via phosphorylation of proteins such as myosin 
phosphatase (MYPT) and LIM kinase (LIMK) (Kaibuchi et al., 1999; Riento and Ridley, 
2003).  Information on the role of ROCK in endocytosis is limited but examples include 
its necessity for sodium, potassium-ATPase endocytosis upon RhoA activation in 
alveolar epithelial cells (Dada et al., 2007) and for rearward clathrin structure 
polarization during the migration of T-lymphocytes (Samaniego et al., 2007).  ROCK 
activation also inhibits epidermal growth factor (EGF) receptor endocytosis in PC12 cells 
(Kaneko et al., 2005).  
RhoA has multiple, differential roles in the trafficking of a variety of other 
membrane proteins.  For example, in alveolar epithelial cells clathrin-dependent sodium, 
potassium-ATPase endocytosis in response to hypoxia is dependent upon RhoA 
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activation (Dada et al., 2007).  In HeLa cells, activation of RhoA inhibits clathrin-
dependent endocytosis of EGF and transferrin (Tf) receptors (Lamaze et al., 1996).  In 
lymphocytes RhoA is required for clathrin-independent, cholesterol-dependent 
internalization of IL-2 receptors (Symons and Rusk, 2003).  Thus, RhoA signaling plays 
both positive and negative roles in a variety of endocytosis pathways.  
Since Kv1.2 regulation was previously shown to be trafficking-dependent (Nesti 
et al., 2004; Williams et al., 2007; Connors et al., 2008), the central hypothesis of this 
thesis is that RhoA regulates Kv1.2 function via modulation of channel trafficking.  We 
report that RhoA does control the trafficking of Kv1.2 and it does this by acting 
through its downstream effectors, primarily ROCK, but also PKN.  Interestingly, we 
have discovered that RhoA controls multiple forms of Kv1.2 trafficking, both under 
steady-state conditions and in response to G protein-coupled receptor signaling.  We 
also show that endocytosis of Kv1.2 occurs through different mechanisms, one being 
cholesterol-dependent, the other clathrin-dependent and we implicate RhoA as critical 
for channel recycling.  In total, this research has established RhoA and its downstream 
effectors as key regulators of Kv1.2 function, with the ultimate implication being that 
RhoA signaling can control cellular excitability.  RhoA, therefore, can potentially serve 
as a therapeutic target for a variety of neuronal and cardiovascular ailments. 
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Figure 1. Steps of an Action Potential
(A) Sodium and potassium ions across the plasma membrane of excitable cells exist 
along opposing concentration gradients.  (B) When an excitatory stimulus depolarizes 
such a cell beyond its excitation threshold, fast-gated sodium channels open, allowing 
positively charged sodium ions to flood into the cell, resulting in further 
depolarization.  Slow-gated potassium channels that respond to the voltage change 
across the plasma membrane open as the sodium channels are inactivated, allowing 
positively charged potassium ions to rush out of the cell.  This effectively moves the 
membrane potential back towards the resting level.  Another action potential cannot 
occur until the cell has returned to its original resting membrane potential.
440mM50mMNa+
20mM400mMK+
Inside Outside
Ion concentrations across the membrane 
of the squid giant axon Kandel & 
Schwartz. Principles of Neural Science. 
2002.
A
http://www.lhsc.on.ca/critcare/ucicu/educate/orient/neuroap.htm
B
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Figure 2. Design and Function of the K+ Selectivity Filter
(A) The pore region of potassium channels contains a highly conserved selectivity 
filter (gold).  Within the selectivity filter are four binding sites for potassium ions.  (B) 
Before potassium ions enter the selectivity filter, they must be dehydrated, costing 
energy.  The radius of the potassium ion is such that once in the filter, it interacts with 
carbonyl oxygen atoms at the binding sites, mimicking hydration, offsetting the cost 
of dehydration.  Other positively charged cations, like sodium are not the proper size 
to interact with these carbonyl oxygens, thus conferring potassium specificity.
MacKinnon, FEBS Letters 555, 62-65 (2003).
A
Alberts et al. Molecular Biology of the Cell. 
2002.
B
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Long et al., Science 309, 897-903 (2005).
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http://nerve.bsd.uchicago.edu/KHTML/sub_struct.htm
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Figure 3. Architecture of Kv1.2
(A) Side-view of the Kv1.2 holochannel illustrating the trans-membrane, pore-
forming region (TM) of the channel, the intracellular tetramerization domain (T1), 
and the associated beta subunits (β).  (B) Top-view of the trans-membrane portion of 
Kv1.2, illustrating the tetramerization of alpha subunits.  (C) Shematic cartoon of an 
individual alpha subunit, clearly showing six alpha-helical membrane-spanning 
domains (S1-S6),  the positively charged voltage sensor helix (S4), and the pore-
forming loop between helices S5 and S6 that dips into the membrane (P)
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Etienne-Mannville et al. Nature 420, 629-635 (2002)
Figure 4. The Rho GTPase Cycle
Rho GTPases cycle between an active (GTP-bound) and in inactive (GDP-bound) 
conformation.  When bound to GTP, they interact with one of many downstream 
proteins, called effectors, and signal through various pathways. Guanine nucleotide 
exchange factors (GEFs) catalyze the exchange of GDP for GTP, causing activation.  
GTPase-activating proteins (GAPs) increase the rate of GTP hydrolysis, leading to 
deactivation.  Guanine nucleotide dissociation inhibitors (GDIs) prevent exchange of 
GDP for GTP and can mask the Rho GTPase C-terminal lipid modification, thus 
holding the protein in an inactive conformation while sequestering it in the cytoplasm.  
Thus, there are many levels of Rho GTPase regulation.
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Riento et al. Biochem. Soc. Trans. 33, 649-651 (2005)
Reproduced with Permission
Figure 5. Downstream Effectors of RhoA
RhoA has the ability to interact with many downstream effectors. These downstream 
effectors signal through various pathways but a key theme is their ability to regulate 
the cytoskeleton.  The extent to which RhoA signals through a particular effector 
depends on the activity level of RhoA, the spatio-temporal dynamics of RhoA 
activation, and the availability of a particular effector at sites of RhoA activity.  
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CHAPTER 2: DUAL ROLES FOR RHOA/RHO-KINASE IN THE REGULATED 
TRAFFICKING OF A VOLTAGE-SENSITIVE POTASSIUM CHANNEL 
 
Introduction 
The voltage-gated potassium channel Kv1.2 regulates diverse physiological 
functions, including the maintenance of action potential proliferation along myelinated 
axons (Rasband et al., 2001; Rasband and Trimmer, 2001; Rasband, 2004),  transduction 
of pain in peripheral sensory neurons (Ishikawa et al., 1999; Kim et al., 2002; Yang et 
al., 2004) and modulation of tone in vascular smooth muscle (Adda et al., 1996; Wang et 
al., 1997; Wang et al., 2005).  Dysregulation of Kv1.2 has been implicated in disease 
states such as hypertension (Cox et al., 2001; Hong et al., 2004), neuropathic pain 
(Ishikawa et al., 1999; Kim et al., 2002; Yang et al., 2004) and seizure activity in the 
central nervous system (Lambe and Aghajanian, 2001; Brew et al., 2007).  Kv1.2 is 
important for maintaining neuronal resting membrane potential (Dodson et al., 2003) and 
is heavily expressed in neurons of the hippocampus and cerebellum (Tsaur et al., 1992; 
Sheng et al., 1994; Veh et al., 1995; Grosse et al., 2000) where it influences neuron firing 
(Laube et al., 1996; Southan and Robertson, 1998; Haghdoust et al., 2007).  
Commensurate with its role as a regulator of cellular physiology, Kv1.2 is itself highly 
regulated.  Understanding the pathways involved in Kv1.2 regulation is therefore 
fundamental to understanding a wide array of physiological processes. 
Negative regulation of Kv1.2 involves tyrosine phosphorylation-dependent 
suppression of its ionic current (Huang et al., 1993).  This can occur in response to a 
 20
variety of stimuli, including the activation of G-protein coupled receptors (Huang et al., 
1993).   Channel suppression by this pathway requires the activity of the small GTPase 
RhoA (Cachero et al., 1998);  inhibition of RhoA GTPase activity with C3 exoenzyme or 
over-expression of a dominant negative form of RhoA  prevents the suppression of Kv1.2 
ionic current in response to channel tyrosine phosphorylation (Cachero et al., 1998).  The 
finding that RhoA modulates Kv1.2 was significant because it provided a new link 
between signaling pathways governing actin dynamics and pathways governing 
membrane excitability. For example, in vascular smooth muscle, both RhoA and Kv1.2 
regulate contractility.  In this tissue, it is well accepted that RhoA acts through direct 
effects on the contractile machinery (Uehata et al., 1997; Nakamura et al., 2003) and that 
Kv1.2 affects contractility indirectly through its effects on membrane potential (Yuan, 
1995; Yuan et al., 1998).   The finding that RhoA affects Kv1.2 function raised the 
intriguing possibility that the effects of Kv1.2 and RhoA on smooth muscle contractility 
may not be distinct, but instead may be tightly connected.  Subsequent studies have 
begun to support this idea (Luykenaar et al., 2004).  Similar links may exist between 
RhoA-regulated actin dynamics and membrane potential in other tissues expressing 
Kv1.2, including neuronal synapses (Dodson et al., 2003).  Despite the evident 
importance of this signaling nexus, the mechanism by which RhoA regulates Kv1.2 is not 
known.   
Tyrosine phosphorylation-dependent suppression of Kv1.2 ionic current involves 
endocytosis of the channel protein from the cell surface (Nesti et al., 2004).   Kv1.2 
endocytosis has at least two distinct components: steady-state channel endocytosis and 
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receptor-induced endocytosis (Williams et al., 2007; Connors et al., 2008).  Both forms 
of Kv1.2 endocytosis require direct association of Kv1.2 with the actin-regulating protein 
cortactin (Hattan et al., 2002; Williams et al., 2007).  Strikingly, each pathway is affected 
by distinct actin-regulatory domains within cortactin (Williams et al., 2007).  Disruption 
of the F-actin binding region within cortactin affects steady-state and receptor induced 
channel endocytosis.  In contrast, disruption of cortactin’s ability to stimulate dendritic 
actin polymerization via Arp2/3 selectively blocks receptor-induced channel endocytosis 
but has no effect on steady-state channel trafficking.  Despite being clearly separable 
based on distinct actin-regulatory functions of cortactin, the mechanisms involved in 
steady-state vs. receptor-induced Kv1.2 endocytosis have remained unclear. 
Since Kv1.2 regulation involves actin-dependent endocytosis, and since RhoA is a 
key modulator of both actin dynamics and endocytosis, I hypothesized that RhoA affects 
Kv1.2 ionic current by modulating channel endocytosis.  This idea is consistent with 
involvement of RhoA in the trafficking of a variety of other membrane proteins.  For 
example, in alveolar epithelial cells clathrin-dependent Na,K-ATPase endocytosis in 
response to hypoxia is dependent upon RhoA activation (Dada et al., 2007), in HeLa cells 
activation of RhoA inhibits clathrin-dependent endocytosis of epidermal growth factor 
(EGF) and transferrin (Tf) receptors (Lamaze et al., 1996), and in lymphocytes RhoA is 
required for clathrin-independent internalization of IL-2 receptors (Symons and Rusk, 
2003).  In some instances, RhoA modulation of endocytosis involves Rho-kinase 
(ROCK).  Perhaps the most well understood RhoA effector, ROCK is a serine/threonine 
kinase that is activated by RhoA (Ishizaki et al., 1996; Matsui et al., 1996).  Examples of 
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RhoA/ROCK dependent endocytosis include a requirement for ROCK in Na,K-ATPase 
endocytosis in alveolar epithelial cells (Dada et al., 2007) and for rearward clathrin 
structure polarization during the migration of T-lymphocytes  (Samaniego et al., 2007).  
ROCK activation inhibits epidermal growth factor (EGF) receptor endocytosis in a 
process involving LIM kinase/cofilin (Kaneko et al., 2005).   In this pathway, RhoA 
activates ROCK, which in turn phosphorylates and activates LIM kinase.  LIM kinase 
then phopshorylates its major substrate, the F-actin severing protein cofilin, thereby 
inactivating it (Bernard, 2007).  This leads to alteration of actin dynamics and modulation 
of endocytosis.  This finding is crucial because it provides a direct link between regulated 
actin dynamics and RhoA-mediated endocytosis.  Despite these intriguing findings, 
evidence linking RhoA, actin dynamics, and endocytosis remains sparse.      
Here we report that RhoA is a determinant of Kv1.2 trafficking.  We show that 
RhoA activity is inversely correlated to the level of channel at the cell surface and that 
this reduction in surface Kv1.2 occurs via channel endocytosis.  These findings reveal 
that steady-state homeostasis of Kv1.2 is achieved through a balance of constitutive, 
cholesterol-dependent endocytosis and channel recycling which is distinct from clathrin-
dependent channel endocytosis elicited by G protein-coupled LPA receptor activation. 
RhoA/ROCK signaling contributes to both forms of trafficking, but does so through 
distinct mechanisms in each case.  In addition, we demonstrate that dynamin is necessary 
for both forms of Kv1.2 trafficking.  Finally, we show that RhoA/ROCK modulates 
Kv1.2 trafficking through LIM kinase/cofilin, thus establishing a direct link between 
RhoA-regulated actin dynamics and the functional regulation of Kv1.2.    
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Materials and Methods 
Materials 
Rabbit polyclonal antibody directed against the first extracellular loop of Kv1.2 (α-
Kv1.2e) was developed in conjunction with Biosource International (Camarillo, CA).   
EEA1 monoclonal (α-EEA1m) and clathrin heavy chain monoclonal (α-CHCm) 
antibodies were purchased from BD Biosciences (Franklin Lakes, NJ).  RhoA 
monoclonal antibody (α-RhoAm) was a generous gift of Dr. S. Yonemura (Center for 
Developmental Biology, RIKEN, Kobe, Japan).  Phospho-MYPT1 (α-pMYPT1p) 
polyclonal and GAPDH (α-GAPDHm) monoclonal antibodies were purchased from 
Millipore (Billerica, MA).   Alexa Fluor-conjugated transferrin, secondary antibodies, 
and phalloidin were purchased from Invitrogen (Carlsbad, CA).  Non-targeting RNAi and 
clathrin heavy chain RNAi were purchased from Dharmacon (Lafayette, CO).  Y27632 
was purchased from EMD Biosciences (San Diego, CA), C3 exoenzyme was purchased 
from Cytoskeleton Inc. (Denver, CO), Lysophosphatidic acid (LPA), forskolin, and 
filipin were purchased from Sigma-Aldrich (St. Louis, MO).  RhoA (T19N), ROCK 
(RB/PH-TT), LIM kinase (D460A), and cofilin (S3A) were generously provided by Dr. 
K. Hahn (University of North Carolina at Chapel Hill), Dr. K. Kaibuchi (Nagoya 
University), Dr. K Suzuki (National Institute of Health Sciences, Tokyo, Japan), and Dr. 
P. Caroni (Friedrich Miescher Institite, Basel, Switzerland) respectively.  Dynasore was 
generously provided by Dr. T. Kirchhausen (Harvard Medical School). 
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Cell culture and transfection 
Human embryonic kidney 293 cells stably expressing Kv1.2-α, Kvβ2 and the M1 
muscarinic acetylcholine receptor (HEK-K) were utilized and cultured as previously 
reported (Nesti et al., 2004).  Experimental plasmid constructs were co-transfected into 
HEK-K cells with pEGFP-N1 using calcium phosphate.  Confluent cultures were plated 
to a density of 3.3 x 104 cells per cm2 onto tissue culture plates or glass cover slips 
(Corning Glass Works, Corning, NY) coated with poly-D-lysine (Sigma-Aldrich, St. 
Louis, MO) (0.1 mg/ml) or plasma fibronectin (0.015 mg/ml) for biochemistry, flow 
cytometry, electrophysiology, and immunofluorescence 12-16 h in serum-free media 
before use. 
Electrophysiology 
All recordings were made on HEK-K cells using the whole-cell patch-clamp method.  
Data were collected using an Axopatch 200 patch-clamp amplifier using pClamp 9.2 
(Axon Instruments, Burlingame, CA).  Currents were collected with step pulses from -70 
to +50 mv in increments of 10 mv from a holding potential of -60 mV and were leak 
subtracted with a P/4 protocol. The pipette solution contained 60 mM K2SO4, 1.2 mM 
KCl, 5 mM MgSO4, 5 mM Na-HEPES, and 35 mM sucrose (pH 7.1). The external (bath) 
solution contained 118 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 5 mM 
Na-HEPES, and 23 mM glucose (pH 7.4). All recordings were made at 37ºC. 
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Detection of surface Kv1.2 
For flow cytometric detection of surface Kv1.2, HEK-K cells were treated with saline, 
vehicle control solution, or an appropriate stimulus, then 154 mM sodium azide as in 
(Nesti et al., 2004).  After azide, the cells were lifted and placed in a test tube where 
surface Kv1.2 was labeled with 0.33 μg/ml α-Kv1.2e.  Antibody binding was detected 
with fluorescently conjugated anti-rabbit IgG (0.1 μg/ml).  Fluorescence was detected by 
flow cytometry as described below. 
Flow cytometry 
A single laser flow cytometer (Easy Cyte PCA-96; Guava Technologies, Hayward, CA) 
was used.  In all HEK-K cells, α-Kv1.2e primary antibody was detected by labeling with 
a goat α-rabbit secondary antibody conjugated to PE/CyTM5 with an excitation peak of 
488nm and an emission peak of 667nm (Southern Biotechnology, Birmingham, AL).  
Surface Kv1.2 in transfected cells was taken as the distribution of cells emitting at 667 
nm (indicating surface Kv1.2) in cells also emitting at 508 nm (indicating GFP 
expression) minus background signal.  Background staining was quantitated in cells using 
goat α-rabbit-PE/CyTM5 without prior application of α-Kv1.2e. 
Immunoblot 
Western analysis of HEK-K whole-cell lysates was performed as previously reported. 
(Connors et al., 2008). 
Immunofluorescence 
Confluent cultures were plated as for flow cytometry and pre-treated as indicated at 37ºC.  
α-Kv1.2e was applied to live cells at 0.33 μg/ml for 10 min at 37ºC.  Cells were fixed 
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with 4% paraformaldehyde (Polysciences, Warrington, PA) in PHEM 6.1 buffer (60 mM 
PIPES, 25 mM HEPES, 2 mM MgCl2, 10 mM EGTA; pH to 6.1 with KOH) at room 
temperature.  Cell were extracted with ice cold acetone.  Coverslips were incubated in 
blocking buffer (PHEM 6.9, 3% goat serum, 0.1% fish skin gelatin) at room temperature.  
Other primary antibodies were then applied (α-EEA1 = 1.25 μg/ml, α-RhoAm = 35.1 
μg/ml, α-CHCm = 2.5 μg/ml) diluted in blocking buffer.  Alexa Fluor-conjugated 
secondary antibodies were applied (4 μg/ml in blocking buffer) (Invitrogen, Carlsbad, 
CA) at room temperature.  F-actin was detected with Alexa Fluor 350 or 488 phalloidin 
(Invitrogen) (4 U/ml).  Coverslips were mounted on glass slides with ProLong Gold 
mounting medium (Molecular Probes) according to the provided protocol.  Images were 
obtained with the DeltaVision reconstruction microscopy system (Applied Precision).   
Transferrin endocytosis assay 
Confluent cultures were plated as for flow cytometry.  Coverslips were washed with 
warm serum-free media, chilled, then incubated for 45 min in cold serum-free media 
containing 25μg/ml Alexa 488-conjugated transferrin.  Coverslips were washed then 
moved to 37ºC for 0 or 15 min.   Coverslips were chilled, washed, and processed for 
immunofluorescence. 
Statistical analysis 
Descriptive statistics are provided in figures as line or bar graphs indicating the sample 
mean with error bars indicating the standard error of the mean (SEM).  Detection of 
statistical difference between two independent measurements was by one-way t-test.  
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Comparison of percent changes between pairs of independent measurements was by two-
way ANOVA.  Sample populations were considered to be significant at p<0.05 
 
Results 
RhoA affects Kv1.2 surface expression 
Tyrosine kinase-dependent suppression of Kv1.2  by M1 muscarinic 
acetylcholine receptors requires RhoA (Cachero et al., 1998). In independent studies, this 
process was shown to occur by channel endocytosis from the plasma membrane (Nesti et 
al., 2004; Williams et al., 2007; Connors et al., 2008).  However it is not known whether 
these two processes are mechanistically linked.  We therefore asked whether Kv1.2 
trafficking at the plasma membrane requires RhoA.   Using flow cytometry as previously 
described (Nesti et al., 2004; Connors et al., 2007; Williams et al., 2007; Connors et al., 
2008), steady-state levels of Kv1.2 at the cell surface were measured in the presence or 
absence of the RhoA-specific inhibitor, C3 exoenzyme.   Treatment of HEK-K cells with 
increasing concentrations of C3 exoenzyme produced a concentration-dependent increase 
of steady-state Kv1.2 at the cell surface (Figure 1A; n=4, *p<0.05, **p<0.01).  In a 
complementary experiment designed to confirm that the C3 exoenzyme effect is specific 
to RhoA, increasing amounts of dominant negative RhoA (T19N) (Subauste et al., 2000) 
were transfected.  This too caused a dose-dependent increase of steady-state surface 
Kv1.2 (Figure 1B; n=18, **p<0.001).  The effectiveness of C3 exoenzyme and RhoA 
(T19N) suggest that RhoA is at least partially active in un-stimulated HEK-K cells.  
Since RhoA translocation to the plasma membrane occurs upon activation (Takaishi et 
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al., 1995), we used immunofluorescence to assess the sub-cellular distribution of RhoA 
in un-stimulated cells.  Strong RhoA immunofluorescence was detected at the cell 
periphery and areas of cell-cell contact (Figure 2, arrows).  RhoA in these areas was 
coincident with Kv1.2 immunofluorescence, consistent with a role for RhoA in regulating 
steady-state trafficking of Kv1.2 at the cell surface.  
RhoA activation triggers Kv1.2 endocytosis 
The lysophosphatidic acid (LPA) receptor couples to G12/13, to potently activate 
RhoA (Moolenaar, 1995; Bian et al., 2006).  Stimulation of endogenous LPA receptors in 
HEK-K cells elicited a significant, concentration-dependent reduction of surface Kv1.2 
(Figure 3A; n=5, *p<0.05, **p<0.01).  Whole-cell patch clamp studies confirmed that the 
loss of surface Kv1.2 induced by LPA (10 μM, 15 min) correlates with a reduction of 
Kv1.2 function.  The mean steady-state current amplitude measured between 60-80 ms 
after depolarization to +20 mV was reduced from 9.4±1.1 nA in saline treated cells to 
4.3±1.4 nA in cells treated with LPA (Figure 3B; n≥11, p<0.01).  To determine whether 
the LPA effect on Kv1.2 surface expression results from its ability to activate RhoA, cells 
were pre-treated with C3 exoenzyme to block RhoA prior to application of LPA.  C3 pre-
treatment reduced the LPA-mediated loss of surface Kv1.2 by approximately 50% 
(Figure 4A, Figure 4B; n=31, *p<0.05, **p<0.01), supporting the assertion that LPA 
activation of RhoA elicits Kv1.2 endocytosis.   To confirm this finding, we took an 
alternate approach whereby RhoA activity was blocked not with C3 exoenzyme, but 
instead by activation of an endogenous inhibitory pathway.  RhoA activity is potently 
inhibited by phosphorylation of serine 188 by protein kinase A (PKA) (Dong et al., 1998; 
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Forget et al., 2002).  Pre-treatment of HEK-K cells with forskolin, an agent shown in 
another study to activate PKA under these experimental conditions (Connors et al., 
2008), strongly inhibits the LPA-induced loss of surface Kv1.2 (Figure 4C; n=15, 
**p<0.001).   Therefore, LPA-induced reduction of functional Kv1.2 channels from the 
cell surface is at least partially dependent on receptor-induced activation of RhoA.    
M1 muscarinic acetylcholine receptor stimulation causes endocytosis of Kv1.2 
to EEA1-containing structures (Nesti et al., 2004).  To confirm that LPA-induced loss of 
surface Kv1.2 also occurs by channel endocytosis, immunofluorescence was used to 
visualize Kv1.2 trafficking in HEK-K cells treated with saline or LPA.  Surface Kv1.2 
was labeled in live cells with α-Kv1.2e before addition of saline or LPA (10 μM, 15 
min), followed by fixation and analysis by immunofluorescence.  LPA treatment resulted 
in translocation of Kv1.2 from the cell periphery to intracellular puncta.  Internalized 
Kv1.2 puncta co-stained with EEA1 or were adjacent to EEA1-containing structures 
(Figure 5), confirming that LPA treatment elicited channel endocytosis.  We also noted 
that LPA-induced internalization of surface Kv1.2 disrupts its distinct co-localization 
with RhoA at the cell periphery (Figure 5).  These data are consistent with an inverse 
relationship between RhoA activity and the level of Kv1.2 at the cell surface and support 
the hypothesis that RhoA exerts its effect on channel function by modulating channel 
endocytosis.  
Rho-kinase (ROCK) is required for LPA-induced Kv1.2 endocytosis 
A major downstream effector of RhoA is Rho-kinase (ROCK), a 
serine/threonine kinase that modulates the actin cytoskeleton and regulates the trafficking 
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of certain membrane proteins  (Narumiya et al., 1997; Kaneko et al., 2005; Dada et al., 
2007; Samaniego et al., 2007).  To test the hypothesis that RhoA effects on Kv1.2 
involve ROCK, we took two distinct approaches to inhibiting ROCK.  First, DNA 
encoding a dominant negative form of  ROCK (RB/PH-TT) (Amano et al., 1999) was 
transfected in into HEK-K cells and the effect on Kv1.2 surface levels and trafficking 
was determined.  Over-expression of dominant negative ROCK resulted in a significant 
increase in levels of Kv1.2 at the cell surface in un-stimulated cells (Figure 6A; n=69, 
**p<0.001).  Strikingly, LPA-induced Kv1.2 endocytosis was significantly reduced in 
ROCK (RB/PH-TT)-expressing cells (Figure 6B; n=69, *p<0.001).  To confirm that 
these effects were caused by blockade of ROCK and not by over-expression of ROCK 
(RB/PH-TT) per-se, we took the complementary approach of blocking ROCK with the 
pharmacological inhibitor Y27632.  Inhibiting ROCK in this way significantly increased 
the steady-state level of surface Kv1.2 (Figure 6C; n=40, *p<0.01, **p<0.001) and 
completely blocked LPA-induced Kv1.2 endocytosis (Figure 6C; n=40, *p<0.01, 
**p<0.001).   To confirm that LPA activates ROCK and that Y27632 exerts its effect on 
Kv1.2 by inhibiting that activation, we used Thr696-phosphorylated myosin phosphatase-
1 (MYPT1) as an indirect measure of ROCK activity (Feng et al., 1999).  LPA treatment 
(10 μM, 15 min) of HEK-K cells increased detectable pMYPT1 while treatment with the 
ROCK inhibitor Y27632 (10 μM, 30 min) reduced levels of pMYPT1 relative to saline 
control (Figure 6D).  Immunofluorescence experiments shown in Figure 7 confirm that 
the effects on surface Kv1.2 observed in flow cytometry experiments (Figure 6C) arise 
from alterations of Kv1.2 trafficking.  LPA elicited a translocation of Kv1.2 from the cell 
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periphery to intracellular puncta, indicative of channel endocytosis (Nesti et al., 2004), an 
effect completely blocked by Y27632 (Figure 7).  Collectively, these findings indicate 
that ROCK is an essential downstream effector for receptor-induced, RhoA-mediated 
endocytosis of Kv1.2.  Since both ROCK (RB/PH-TT) over-expression and Y27632 
treatment cause an increase of steady-state surface Kv1.2, these findings also indicate that 
basal ROCK activity is important downstream of RhoA for maintaining steady-state 
Kv1.2 at the cell surface as well.    
LPA-induced Kv1.2 endocytosis is clathrin-dependent 
Although Kv1.2 endocytosis can be elicited by a variety of signals (Huang et al., 
1993; Nesti et al., 2004; Williams et al., 2007; Connors et al., 2008), the specific 
endocytosis pathways involved are not known.  Many cell-surface proteins and ion 
channels are internalized in a clathrin-dependent manner, among them the transferrin (Tf) 
receptor, epidermal growth factor (EGF) receptor, as well as the epithelial sodium 
channel (ENaC) (Sorkin and Waters, 1993; Shimkets et al., 1997; Rotin et al., 2001).  We 
therefore sought to explore the role of clathrin in RhoA/ROCK-mediated endocytosis of 
Kv1.2.  Knockdown of clathrin protein with RNAi inhibits Tf receptor internalization 
(Hinrichsen et al., 2003). We chose this approach to explore the role of clathrin in Kv1.2 
endocytosis.  To validate the efficacy of clathrin RNAi in HEK-K cells, clathrin protein 
levels were determined in cells transfected with non-targeting (NT) RNAi or with RNAi 
targeting clathrin.  Transfection of clathrin RNAi reduced clathrin protein levels by 50% 
compared to cells transfected with NT RNAi, as detected by immunoblot (Figure 8A; 
n=8, **p=0.008).  Comparable results were obtained from immunofluorescence 
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experiments (Figure 8B, Figure 8C), where clathrin signal intensity was reduced by 30% 
compared to NT control (Figure 8C; n=37, *p=0.035).  This level of reduction was 
sufficient to interfere with clathrin-dependent endocytosis since Tf receptor 
internalization, as viewed by immunofluorescence (Figure 9A), was reduced 
approximately 3-fold in cells transfected with clathrin RNAi compared to NT RNAi 
control (Figure 9B; n=17, *p<0.05, **p<0.001).  Thus, knockdown of clathrin protein in 
HEK-K cells is an effective way to inhibit clathrin-dependent endocytosis.   Application 
of this technique to Kv1.2 revealed that clathrin RNAi reduced Kv1.2 endocytosis in 
response to LPA by 50% (Figure 10A, Figure 10B; n=33, *p<0.05, **p<0.001).  This 
result is consistent with a 50% knockdown of clathrin protein by RNAi transfection.  
Interestingly, despite its effect on LPA-induced Kv1.2 endocytosis, inhibiting clathrin-
mediated trafficking had no detectable effect on the steady-state level of surface Kv1.2 
(Figure 10A).  Moreover, clathrin knockdown had no effect on the ability of Y27632 to 
elevate surface Kv1.2 levels (Figure 10C; n=33, p=0.493). These findings suggest the 
intriguing hypothesis that LPA-induced endocytosis of Kv1.2 is clathrin-dependent while 
the trafficking mechanism responsible for maintaining the steady-state level of surface 
channel is clathrin-independent, despite both processes being regulated by RhoA/ROCK. 
Steady-state endocytosis of Kv1.2 is cholesterol-dependent 
We next sought to determine the trafficking pathway involved in steady-state 
regulation of Kv1.2 at the cell surface.  To assess the role of cholesterol in steady-state 
trafficking, we made use of the sterol-binding agent filipin to disrupt cholesterol-rich 
regions of the plasma membrane (Chang et al., 1992; Rothberg et al., 1992; Schnitzer et 
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al., 1994; Smart et al., 1994).  Steady-state surface levels of Kv1.2 were significantly 
increased in the presence of filipin while subsequent Y27632 application had no additive 
effect (Figure 11A; n=32, *p<0.01, **p<0.001).  In contrast, filipin did not block LPA- 
induced Kv1.2 endocytosis, rather it was significantly enhanced, suggesting that higher 
levels of steady-state surface Kv1.2 creates a larger pool of channel available for LPA-
induced, clathrin-dependent endocytosis (Figure 11B, Figure 11C; n=5, *p<0.05, 
**p<0.001).  These findings also suggest that basal ROCK activity modulates steady-
state surface Kv1.2.  Additionally, cholesterol-dependent endocytosis operates 
constitutively, controlling the steady-state surface level of Kv1.2 independently of the 
clathrin-dependent mechanism elicited by G protein-coupled LPA receptor stimulation.   
In many instances, steady-state levels of proteins at the plasma membrane 
represent a homeostasis between endocytosis and recycling back to the plasma membrane 
(Dunn and Hubbard, 1984; Morrison et al., 1996; Leterrier et al., 2004).  While filipin is 
widely used to block cholesterol-dependent endocytosis, it can have other effects on 
trafficking, including modulation of intracellular vesicular trafficking and recycling 
pathways (Kwik et al., 2003).  We therefore asked whether filipin’s effect on Kv1.2 
involved one or both of these processes.  To do so, we used low temperature (16° C) to 
block intracellular vesicle trafficking and recycling.  This manipulation leaves 
endocytosis from the plasma membrane intact (De Camilli et al., 1995; Le and Nabi, 
2003), thus enabling us to study channel recycling and channel endocytosis in relative 
isolation of one another.  Incubation of HEK-K cells at 16° C for 1 hour reduced steady-
state surface Kv1.2 by approximately 50% relative to control cells maintained at 37° C 
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(Figure 12E; n=27, **p<0.001).  This profound drop in surface Kv1.2 levels indicated 
that recycling does play a key role in the maintenance of surface Kv1.2.  In striking 
contrast, temperature block of recycling did not impair the ability of filipin to potently 
increase the level of surface Kv1.2 (Figure 12A, Figure 12B; n=12, *p=0.019, 
**p<0.001).   This finding confirms that, although recycling has an important role in 
maintaining levels of surface Kv1.2, filipin blockade of cholesterol-dependent steady-
state Kv1.2 endocytosis is sufficient to increase surface channel levels.  However, it also 
raises the question of which branch of this homeostatic pathway is acted upon by ROCK?  
We therefore used temperature block in combination with ROCK inhibition to address 
this question.  Under these conditions, temperature block completely prevented the 
Y27632-induced increase of surface Kv1.2 (Figure 12C, Figure 12D; n>10, *p<0.01, 
**p<0.001).  Based on these results, we surmise that basal ROCK activity in un-
stimulated HEK-K cells exerts its effect on steady-state surface Kv1.2 not by reducing 
cholesterol-dependent channel endocytosis per se, but by reducing the recycling of 
constitutively endocytosed channel back to the plasma membrane. 
Dynamin is essential for both steady-state and LPA-induced modulation of Kv1.2 
trafficking 
Dynamin is a small GTPase with a well-established role in both cholesterol-
dependent and clathrin-dependent endocytosis  (De Camilli et al., 1995; Sever et al., 
2000).  It was previously reported that tyrosine kinase-induced endocytosis of Kv1.2 is 
dynamin dependent (Nesti et al., 2004).  We therefore asked whether dynamin is also 
necessary for RhoA/ROCK-mediated endocytosis of Kv1.2.  The small-molecule 
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inhibitor, dynasore (Macia et al., 2006) was used to block the GTPase activity of 
dynamin.  Increasing concentrations of dynasore applied to un-stimulated HEK-K cells 
(30 min at 37ºC) elicited a significant, concentration-dependent increase of surface Kv1.2 
(Figure 13A; n=3, *p<0.01, **p<0.001).  To ascertain the role of dynamin in stimulus-
induced Kv1.2 trafficking, surface Kv1.2 levels were measured in LPA and Y27632-
treated cells in the presence or absence of a maximal concentration of dynasore.  
Application of Y27632 (10 μM, 30 min) in control cells elicited a significant increase in 
surface channel levels, however it had no effect in cells pre-treated with 80 μM dynasore 
(Figure 13B; n=6, *p<0.05, **p<0.001).  Similarly, LPA (10 μM, 15 min) caused a 
significant decrease in surface Kv1.2 levels in control cells, but its effect was abolished in 
cells pre-treated with dynasore (Figure 13B; n=6, *p<0.05, **p<0.001).  We conclude 
that dynamin is necessary for both steady-state homeostasis of surface Kv1.2, and 
clathrin-dependent, LPA-induced Kv1.2 endocytosis.  
ROCK modulates Kv1.2 trafficking through LIM kinase/cofilin 
Previous studies have indicated a role for actin remodeling by the Arp2/3 protein 
complex in Kv1.2 trafficking (Hattan et al., 2002; Williams et al., 2007; Connors et al., 
2008).  This was intriguing since cofilin, an actin-severing protein, also interacts with 
Arp2/3 to remodel actin (Ichetovkin et al., 2002).  Cofilin’s actin-severing activity is 
regulated through phosphorylation-dependent inhibition by LIM kinase (LIMK), which 
itself can be activated by ROCK (Bernard, 2007).  We therefore assessed the role of 
LIMK in Kv1.2 trafficking by over-expressing a dominant negative LIMK (D460A) that 
lacks kinase activity (Matsui et al., 2002).  In un-stimulated HEK-K cells, steady-state 
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levels of surface Kv1.2 are significantly increased in the presence of LIMK (D460A) 
(Figure 14A; n=78, **p<0.001).  When LPA was applied (10 μM, 15 min) in the 
presence of LIMK (D460A), loss of surface Kv1.2 was blocked (Figure 14B, Figure 14C; 
n=21, ^p<0.05, *p<0.01, **p<0.001).  The Y27632-induced increase of surface Kv1.2 
was not significantly affected by over-expression of LIMK (D460A) (Figure 14D; n=21, 
p=0.143).  In addition, transfection of increasing amounts of DNA encoding an active 
form of cofilin (S3A) that cannot be phosphorylated and deactivated by LIMK (Arber et 
al., 1998) results in a concentration-dependent increase of steady-state surface Kv1.2 
(Figure 15; n=12, *p<0.01, **p<0.001).  Over-expression of active cofilin was designed 
to mimic the presence of LIMK (D460A).  These results suggest that the LIMK/cofilin 
pathway is partially responsible for controlling steady-state channel endocytosis, but not 
channel recycling, as evidenced by a persistent Y27632-induced increase of surface 
Kv1.2 in the presence of LIMK (D460A).  Additionally and importantly, the 
LIMK/cofilin pathway is essential for RhoA-mediated Kv1.2 suppression via LPA 
receptor activation. 
 
Discussion 
Potassium channel regulation is a fundamental means for controlling cellular 
excitability.  In this chapter we report that RhoA signals through ROCK to regulate 
potassium ion channel trafficking.  We show that the Kv1.2 potassium channel is subject 
to two independent forms of trafficking at the plasma membrane, one modulates the 
homeostasis of Kv1.2 at the cell surface and the other results in acute Kv1.2 endocytosis 
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following G protein-coupled receptor activation.  Intriguingly, we found that 
RhoA/ROCK has a central role in both forms, but that it affects distinct stages of 
trafficking for each.  Acute endocytosis of Kv1.2 is clathrin-dependent and RhoA/ROCK 
is required for internalization of the channel from the plasma membrane.  In contrast, 
RhoA/ROCK also appears to modulate steady-state surface homeostasis, which involves 
cholesterol-dependent trafficking, not at the internalization stage, but later at the point of 
Kv1.2 recycling back to the plasma membrane.  This study therefore not only unites two 
previous studies, one showing that RhoA has a central role in the tyrosine kinase-
dependent suppression of Kv1.2 ionic current (Huang et al., 1993) and the other 
identifying endocytosis as a key mechanism for the suppression of Kv1.2 (Nesti et al., 
2004), it also provides new insight into the complex and still poorly understood role of 
RhoA in regulating membrane protein trafficking in general.   
Using both pharmacological inhibition and over-expression of dominant negative 
RhoA we showed that RhoA activity inversely correlates to the level of Kv1.2 at the cell 
surface.  Application of C3 exoenzyme or over-expression of a dominant negative form 
of RhoA both caused significant and dose-dependent increases in Kv1.2 present at the 
cell surface (Figure 1).  These findings are supported by immuonofluoresence data 
showing co-localization of RhoA at the cell periphery in un-stimulated cells (Figure 2) 
since such peripheral localization is expected for active, but not inactive RhoA (Takaishi 
et al., 1995).  In addition to regulating steady-state levels of Kv1.2 at the cell surface, 
RhoA is required for the acute regulation of the channel.  Our finding that Kv1.2 surface 
levels and ionic current are negatively regulated by activation of G protein-coupled LPA 
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receptors is consistent with previous studies reporting similar effects with  muscarinic 
acetylcholine receptors (Cachero et al., 1998; Hattan et al., 2002; Nesti et al., 2004; 
Williams et al., 2007) (Figure 3).  LPA receptors can couple to G12/13 to activate RhoA 
(Moolenaar, 1995; Bian et al., 2006); that they do so here is confirmed by the ability of 
C3 exoenzyme to inhibit the LPA-induced endocytosis of Kv1.2 (Figure 4A, Figure 4B).  
We note that C3 exoenzyme blockade of LPA-induced endocytosis is not complete.  This 
could result from LPA triggering parallel pathways to modulate Kv1.2, only one of which 
involves RhoA (Bian et al., 2006).  Alternatively, inhibition of RhoA by C3 exoenzyme 
may not have been complete under the experimental conditions used.  We view the latter 
as more likely since inhibition of the RhoA downstream effector ROCK with Y27632 
completely inhibited LPA-induced channel endocytosis (Figure 6, Figure 7).  This result 
suggested that RhoA is the primary conduit for LPA effects on Kv1.2.     
Although several studies have examined the relationship between Kv1.2 function 
and its endocytosis (Nesti et al., 2004; Williams et al., 2007; Connors et al., 2008), the 
mechanisms by which Kv1.2 undergoes endocytosis remained unclear.  An earlier report 
(Williams et al., 2007) as well as the data shown in Figures 1-7 indicate that Kv1.2 in the 
plasma membrane is subject to both steady-state and acute regulation.  Here we report 
that steady-state regulation of Kv1.2 involves cholesterol-dependent channel 
internalization, and that acute, receptor-induced endocytosis proceeds through a separate, 
clathrin-dependent mechanism.  These studies used a combination of clathrin knock-
down and cholesterol sequestration to functionally isolate these two pathways.  In Figure 
11 we show that application of the sterol-binding agent, filipin, caused an accumulation 
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of Kv1.2 at the cell surface.  It is notable that filipin does not block LPA-induced channel 
endocytosis despite having blocked cholesterol-dependent endocytosis (Figure 11B, 
Figure 11C).  This result could be explained if more than one pool of Kv1.2 exists.  A 
pool of Kv1.2 subject to cholesterol-dependent endocytosis may be isolated from the 
clathrin endocytosis machinery, possibly by being sequestered in lipid rafts.  Disruption 
of those rafts with filipin could have potentially made additional channel available for 
endocytosis via the clathrin-dependent pathway activated by the LPA receptor.  
Localization of Kv1.2 to cholesterol-rich domains is plausible given that such localization 
has been demonstrated for the closely related channels Kv1.3 and Kv1.5 (Martens et al., 
2001; Martinez-Marmol et al., 2008; Vicente et al., 2008).  We also note that clathrin-
dependent endocytosis can be affected by depletion of cholesterol (Lajoie and Nabi, 
2007), and caution must be exercised when attributing the effects observed with 
cholesterol sequestering drugs to a clathrin-independent pathway.  In Figure 10A we 
show that RNAi knockdown of clathrin protein did not alter the level of steady-state 
surface Kv1.2 but completely abolished LPA-induced channel endocytosis.  Clathrin 
knockdown in these experiments was functionally effective since it significantly reduced 
Tf receptor endocytosis (Figure 9).  Therefore, in this experimental system, filipin and 
clathrin RNAi are effective means of functionally isolating cholesterol and clathrin 
dependent endocytosis.    
The contribution of RhoA/ROCK to clathrin-dependent endocytosis is well 
established (Muro et al., 2003; Nishimura et al., 2003; Samaniego et al., 2007).  The role 
of RhoA/ROCK in cholesterol-dependent endocytosis is less well studied but has also 
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been described (Mayor and Pagano, 2007).  We show that although RhoA/ROCK affects 
both pathways as it pertains to Kv1.2 trafficking, the mechanisms by which it does so are 
distinct.  Using low temperature to inhibit intracellular trafficking we found that, 
compared to 37ºC control, surface Kv1.2 levels are significantly reduced but remained 
sensitive to cholesterol sequestration with filipin (Figure 12A, Figure 12B, Figure 12E).  
This finding is consistent with the expected selective block of channel recycling but not 
of constitutive channel endocytosis at low temperature.  Remarkably, although it did not 
inhibit filipin’s ability to increase surface Kv1.2 levels, temperature block of channel 
recycling completely abolished the Y27632-induced increase in surface Kv1.2 levels 
(Figure 12C, Figure 12D).  This result suggested that basal ROCK functions as a negative 
regulator of Kv1.2 recycling to the plasma membrane.  Collectively, these findings 
indicate that steady state Kv1.2 levels are governed by a homeostatic balance between 
cholesterol-dependent channel endocytosis and subsequent recycling back to the plasma 
membrane, and that RhoA/ROCK signaling affects only the recycling component of this 
pathway.     
Clathrin-dependent endocytosis is, generally, dynamin-dependent.  In contrast, 
clathrin-independent modes of endocytosis can proceed with or without a requirement for 
dynamin (Mayor and Pagano, 2007).  In a previous study, Kv1.2 endocytosis via  
muscarinic acetylcholine receptor stimulation was reported to be dynamin-dependent 
(Nesti et al., 2004).  Here we show that inhibition of the GTPase activity of dynamin with 
the small-molecule inhibitor dynasore (Macia et al., 2006) blocks both constitutive and 
LPA-induced Kv1.2 endocytosis (Figure 13).  Since receptor-induced and steady-state 
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Kv1.2 trafficking occur through distinct mechanisms, it is likely that dynamin has 
different functional roles in each case. We believe that the most likely mechanism for 
dynamin in LPA-induced channel endocytosis is through its classical role as a pinchase 
for clathrin-coated vesicles (Danino et al., 2004).  Dynamin’s roles in other forms of 
trafficking are less clear, although mounting evidence indicates that it has a key role in 
intracellular vesicle trafficking by modulating actin dynamics in coordination with 
cortactin  (Williams et al., 2007).  A previous study identified distinct domains within 
cortactin that are required for the independent regulation of steady-state or receptor 
induced Kv1.2 trafficking (Williams et al., 2007).  Collectively, these findings raise the 
intriguing possibility that RhoA, cortactin and dynamin act in concert to regulate channel 
trafficking through their effects on actin dynamics.       
The idea that RhoA/ROCK affects channel trafficking through an actin-dependent 
mechanism is shown more directly with the finding that ROCK modulates Kv1.2 
trafficking through LIM kinase/cofilin (Figure 14, Figure 15).  Over-expression of a 
dominant negative form of LIMK or an active form of cofilin elicits an increase in 
steady-state surface channel levels (Figure 14A, Figure 15).   Dominant negative LIMK 
significantly reduces LPA-induced endocytosis of Kv1.2 (Figure 14B, Figure 14C).  
Strikingly, dominant negative LIMK had no significant effect on the elevation of surface 
Kv1.2 levels that occurs following ROCK inhibition with Y27632 (Figure 14D).  We 
surmise that LIMK affects the internalization phase of the steady-state and receptor-
induced pathways for Kv1.2 endocytosis, but does not modulate ROCK-dependent Kv1.2 
recycling.  This is consistent with other reports of a requirement for LIMK activity in the 
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internalization of beta-adrenergic (Volovyk et al., 2006) and EGF (Nishimura et al., 
2004) receptors.  This is not unexpected since LIMK can be activated by multiple 
upstream proteins in addition to ROCK, such as PAK (Edwards et al., 1999; Dan et al., 
2001; Sumi et al., 2001b).  Involvement of LIM kinase/cofilin in both the steady-state 
and receptor-induced trafficking of Kv1.2 is particularly informative in view of a similar 
dual role for the actin regulating protein cortactin (Williams et al., 2007).  This 
convergence at the level of Kv1.2 trafficking, as well as the reported ability of cofilin and 
cortactin to act in concert to regulate actin dynamics (Yamaguchi and Condeelis, 2007; 
Lai et al., 2008), suggests that Kv1.2 trafficking through both cholesterol and clathrin-
dependent pathways involves a complex interaction of multiple actin-regulatory systems.       
Phosphorylation of proteins is particularly important for the regulated trafficking 
of Kv1.2.  In this chapter we demonstrated that ROCK is critical for both steady-state 
Kv1.2 homeostasis and for LPA-induced Kv1.2 endocytosis.  ROCK is a serine/threonine 
kinase whose activity is enhanced by interacting with active RhoA (Ishizaki et al., 1996; 
Matsui et al., 1996).  When activated, ROCK goes on to modulate many cytoskeleton-
based processes in the cell by phosphorylating downstream proteins such as LIM kinase 
(LIMK) (Kaibuchi et al., 1999; Riento and Ridley, 2003), which we demonstrated is also 
critical for steady-state and stimulus-induced Kv1.2 trafficking.  In the absence of ROCK 
phosphorylation, the N-terminus of LIMK performs an auto-inhibitory function towards 
the catalytic domain (Edwards and Gill, 1999).  ROCK-mediated phosphorylation of 
LIMK occurs in a specific region of its catalytic domain called the activation segment 
which is an enzyme-specific region between highly conserved sequence motifs DFG and 
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APE (Taylor and Radzio-Andzelm, 1994).  Activation and relief of LIMK auto-inhibition 
occurs upon its phosphorylation by ROCK on threonine 508 (LIMK1) or threonine 505 
(LIMK2) within the activation segment (Ohashi et al., 2000; Sumi et al., 2001a).  A 
downstream target of LIMK is cofilin, an actin-binding protein that promotes the 
turnover and dynamic polymerization of actin filaments (Arber et al., 1998; Ichetovkin et 
al., 2002; Bernard, 2007).  We have also touched upon the role of cofilin for Kv1.2 
trafficking in this chapter.  LIMK phosphorylates cofilin on serine 3 which leads to its 
inactivation and subsequent accumulation of filamentous actin (Arber et al., 1998).  
Inactivation of cofilin is a function of phosphorylation-dependent inhibition of the ability 
of cofilin to bind filamentous actin (Blanchoin et al., 2000; Chen et al., 2002; Maciver 
and Hussey, 2002). 
The discovery that RhoA/ROCK is necessary for both the constitutive and 
stimulus-induced regulation of the same protein, Kv1.2, is significant because it broadens 
the overall view of how RhoA can regulate membrane protein trafficking.  The finding 
that RhoA/ROCK can affect two modes of Kv1.2 trafficking also suggests a mechanism 
by which RhoA can differentially regulate membrane potential in response to distinct 
regulatory signals.  In one instance, low levels of RhoA/ROCK activity couple to a 
cholesterol-dependent Kv1.2 trafficking system, thereby affecting steady-state resting 
membrane potential.  High levels of RhoA/ROCK, in contrast, affect a parallel but 
distinct mechanism for Kv1.2 endocytosis requiring clathrin.   
Initially, the central hypothesis of this thesis may have seemed to take only a 
small step forward in furthering our understanding of how Kv1.2 is regulated because it 
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aimed to connect RhoA-mediated Kv1.2 ionic current regulation and CCh-induced, 
tyrosine phosphorylation-dependent Kv1.2 endocytosis by demonstrating that RhoA 
activation induces channel internalization.  However, in the course of this work we also 
uncovered new cell biological mechanisms that operate to control Kv1.2 function, 
providing additional context through which previously published pathways that regulate 
the channel can be better understood and further highlighting the interconnectedness of 
Kv1.2 regulatory pathways. 
 Signals that modulate the actin cytoskeleton have become a major focus of this 
research since the discovery that RhoA, a well-known actin regulatory protein, is 
involved in CCh-induced, tyrosine phosphorylation-dependent Kv1.2 ionic current 
suppression (Cachero et al., 1998).  The paper that first implicated endocytosis as a 
mechanism of Kv1.2 regulation showed that an intact actin cytoskeleton was required to 
maintain steady-state homeostasis of the channel (Nesti et al., 2004).  Others have 
demonstrated that the actin-binding protein cortactin is essential for both steady-state 
Kv1.2 homeostasis and for CCh-induced endocytosis (Hattan et al., 2002; Williams et al., 
2007).  Distinct functional domains within cortactin confer the ability of the protein to 
modulate these two processes independently (Williams et al., 2007).  Additionally, 
previous data (Nesti et al., Unpublished data) suggested that clathrin-dependent 
endocytosis was the mechanism through which CCh induces Kv1.2 internalization.   
In this chapter, we show that RhoA/ROCK, like cortactin, has dual roles in 
regulating Kv1.2 at the cell surface.  Our demonstration that LIM kinase (LIMK) and 
cofilin are involved downstream of ROCK in Kv1.2 trafficking further strengthens the 
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link between cytoskeletal regulation and control of cellular excitability.  Moreover, 
cofilin and cortactin are known to coordinately modulate the actin cytoskeleton through 
Arp2/3 (Ichetovkin et al., 2002), further strengthening the connections between 
individual Kv1.2 regulatory pathways.  We have presented strong evidence that clathrin-
dependent endocytosis is responsible for stimulus-induced Kv1.2 internalization and have 
shown that other forms of endocytosis also control channel trafficking.  Overall, the data 
contained within this chapter advances our knowledge of how Kv1.2 trafficking occurs 
and it also supports and strengthens assertions from previous published studies.  We 
propose a model (Figure 16) in which Kv1.2 surface expression, and thus activity, is 
modulated by the combined effects of multiple actin-regulating proteins, including 
dynamin, RhoA, ROCK, LIMK, and cofilin acting through distinct trafficking pathways. 
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Figure 1. RhoA Activity Can Modulate Levels of Surface Kv1.2
(A) Application of increasing concentrations of C3 exoenzyme (6 h) to HEK-K cells 
significantly increases the level of steady-state surface Kv1.2 as detected by flow 
cytometry (n=4, *p<0.05, **p<0.01). (B) Transient transfection of increasing amounts 
of DNA encoding a dominant negative form of RhoA (T19N) significantly increases 
the level of steady-state surface Kv1.2 in a concentration-dependent manner (n=18, 
**p<0.001).  
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Figure 2. Surface Kv1.2 Co-localizes with RhoA in Un-stimulated HEK-K Cells
Under steady-state conditions surface Kv1.2 exists in regions of the cell enriched with 
RhoA.  In HEK-K cells surface Kv1.2 was labeled with α-Kv1.2e (green) and total 
RhoA was labeled with α-RhoAm (red).  Specific areas of overlap are indicated 
(arrows).
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Figure 3. RhoA Activity and Surface Kv1.2 are Inversely Correlated
(A) Application of increasing concentrations of lysophosphatidic acid (LPA) (15 min) 
significantly reduces the level of Kv1.2 at the cell surface in a concentration-
dependent manner as detected by flow cytometry (n=5, *p<0.05, **p<0.01).  (B) 
Average whole-cell currents evoked in HEK-K cells with pulses from -70 to +50 mv
in increments of 10 mv in the presence of saline or LPA (10 μM, 15 min). LPA 
application significantly reduces mean whole-cell currents. Current traces for each 
condition represent the average of at least 11 cells (n=11, p<0.01). 
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Figure 4. RhoA Inhibitors Reduce LPA-induced Kv1.2 Suppression
(A) Pre-treatment of HEK-K cells with C3 exoenzyme (0.5 μg/ml, 6 h) significantly 
increases steady-state surface Kv1.2 although LPA-induced suppression of Kv1.2 still 
occurs as detected by flow cytometry (n=31, **p<0.01).  (B) LPA-induced 
suppression of Kv1.2 is significantly reduced in the presence of C3 exoenzyme (n=31, 
*p<0.05).  (C) Application of the adenylate cyclase activator forskolin (10μM, 10 
min) significantly increases the level of Kv1.2 at the cell surface and strongly inhibits 
LPA-induced suppression of the channel.(n=15, **p<0.001).  (D) LPA-induced 
suppression of Kv1.2 is significantly reduced in the presence of forskolin (n=15, 
**p<0.001).
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Figure 5. Activation of RhoA Triggers Kv1.2 Endocytosis
In HEK-K cells, LPA application (10 μM, 15 min) results in translocation of Kv1.2 
(green) from the edge of the cell to intracellular puncta that contain EEA1 or are 
adjacent to EEA1-containing structures (right column).  EEA1 was labeled with α-
EEA1m (red).  Overlap of surface Kv1.2 and total RhoA (red) is highly reduced in 
these intracellular puncta (right column). 
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Figure 6. LPA-induced Kv1.2 Endocytosis Requires ROCK
(A) Over-expression of a dominant negative form of ROCK (RB/PH (TT)) in HEK-K 
cells significantly increases steady-state levels of surface Kv1.2. LPA-induced 
suppression still occurs as detected by flow cytometry (n=69, **p<0.001). (B) LPA-
induced suppression of Kv1.2 is significantly reduced in the presence of dominant 
negative ROCK (n=69, **p<0.001).  (C) Pre-treatment with the ROCK inhibitor 
Y27632 (10 μM, 30 min) prevents LPA-induced endocytosis of Kv1.2.  Y27632, 
when applied alone, significantly increases surface Kv1.2 levels above that of saline 
control (n=40, *p<0.01, **p<0.001).  (D) Application of LPA (10 μM, 15 min) 
stimulates ROCK activity while application of Y27632 inhibits basal ROCK activity 
as measured by immunoblot of phosphorylated myosin phosphatase 1 (pMYPT1).  
pMYPT1 was detected with α-pMYPT1p.  GAPDH was detected with α-GAPDHm
as a loading control. 
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Figure 7.  ROCK Inhibition Prevents LPA-induced Kv1.2 Endocytosis
In HEK-K cells, pre-treatment with Y27632 (10 μM, 30 min) blocks the translocation 
of Kv1.2 from the edge of cells to intracellular puncta upon stimulation with LPA (10 
μM, 15 min). Surface Kv1.2 was labeled with α-Kv1.2e before stimulation with 
control saline or LPA.  
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Figure 8. Clathrin RNAi Reduces Clathrin Protein in HEK-K Cells
(A) Transfection of HEK-K cells with RNAi directed against the heavy chain of 
human clathrin depletes clathrin protein by 50% compared to non-targeting RNAi 
control.  Clathrin heavy chain protein was detected with α-CHCm.  GAPDH was 
detected with α-GAPDHm as a loading control (n=8; **p=0.008).  (B) 
Immunofluorescence of single optical slices through the center of HEK-K cells 
illustrates that clathrin RNAi reduces clathrin signal intensity compared to non-
targeting control both at 0 min and 15 min incubation at 37ºC.  Clathrin heavy chain 
was detected with α-CHCm.  (C) Quantitation of immunofluorescence images reveals 
that clathrin RNAi reduces clathrin signal intensity by approximately 30% compared 
to non-targeting control (n=37; *p=0.035).  
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Figure 9. Clathrin RNAi Impairs Transferrin Receptor Internalization
(A) Immunofluorescence of single optical slices through the center of HEK-K cells 
illustrates that clathrin RNAi reduced the number of internalized Alexa Fluor 488-
conjugated transferrin-containing puncta compared to non-targeting RNAi control 
after 15 min incubation at 37ºC.  (B) Quantitation of immunofluorescence images 
reveals that transferrin uptake is reduced 3-fold in cells with clathrin RNAi compared 
to cells with non-targeting RNAi control (n=17; *p<0.05, **p<0.001).
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Figure 10. LPA-induced Kv1.2 Endocytosis is Clathrin-dependent
(A) Flow cytometric analysis of HEK-K cells reveals that clathrin RNAi reduces 
LPA-induced endocytosis of Kv1.2 while having no effect on steady-state surface 
Kv1.2 levels.  Treatment with Y27632 (10 μM, 30 min) significantly increases surface 
Kv1.2 in the absence or presence of clathrin RNAi (n=33; *p<0.05, **p<0.001).  (B) 
LPA-induced Kv1.2 endocytosis is reduced by approximately 50% in the presence of 
clathrin RNAi (n=33; *p<0.05).  (C) The effect of Y27632 is not significantly altered 
by the presence of clathrin RNAi (n=33; p=0.493).
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Figure 11. Constitutive Cholesterol-dependent Endocytosis is Critical for Kv1.2 
Homeostasis
(A) Application of the sterol-binding agent filipin (7.7 μM, 1 h) to HEK-K cells 
significantly increases steady-state surface Kv1.2 as detected by flow cytometry.  
Subsequent treatment with Y27632 (10 μM, 30 min) does not elicit a further increase 
(n=32; *p<0.01, **p<0.001).  (B) Filipin application does not prevent LPA-induced 
Kv1.2 endocytosis upon application of LPA (10 μM, 15 min) (n=5; *p<0.05, 
**p<0.001).  (C) LPA-induced Kv1.2 endocytosis is significantly increased in the 
presence of filipin (n=5; *p<0.05).
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Figure 12. Constitutive Recycling is Critical for Kv1.2 Homeostasis
(A) Application of filipin (7.7 μM, 1 h) to HEK-K cells significantly increases surface 
Kv1.2 at both 37ºC and 16ºC as detected by flow cytometry (n=12; **p<0.001).  (B) 
Application of filipin at 16ºC results in a significantly larger increase of surface Kv1.2 
compared to 37ºC control (n=12; *p=0.019).  (C) Y27632 (10 μM, 10 min) does not 
elicit an increase of steady-state surface Kv1.2 at 16ºC (n>10; **p<0.001).  (D) 
Application of Y27632 at 16ºC results in virtually no increase of surface Kv1.2 
compared to 37ºC control (n>10, **p<0.01).  (E) Incubation at 16ºC results in 
significantly reduced levels of steady-state surface Kv1.2 compared to 37ºC control 
(n=27, **p<0.001).
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Figure 13. Dynamin is Essential for Steady-state Homeostasis and LPA-induced 
Kv1.2 Endocytosis
(A) Treatment of un-stimulated HEK-K cells with increasing concentrations of 
dynasore (30 min at 37ºC) results in a significant, concentration-dependent increase in 
steady-state surface Kv1.2 as detected by flow cytometry (n=3; *p<0.01, **p<0.001).  
(B) LPA (10 μM, 15 min) and Y27632 (10 μM, 30 min) have no effect in the presence 
of dynasore (n=6; *p<0.05, **p<0.001). 
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Figure 14. LIM Kinase Modulates Kv1.2 Trafficking Downstream of ROCK
(A) Over-expression of a dominant negative form of LIM kinase 1 (D460A) 
significantly increases steady-state surface Kv1.2 in HEK-K cells as detected by flow 
cytometry (n=78; **p<0.001).  (B) LIM kinase 1 (D460A) inhibits LPA-induced 
endocytosis of Kv1.2.  Y27632 (10 μM, 30 min) elicits an increase in surface Kv1.2 in 
the absence or presence of LIM kinase 1 (D460A) (n=21; ^p<0.05, *p<0.01, 
**p<0.001).  (C) In the presence of LIM kinase 1 (D460A), LPA-induced Kv1.2 
endocytosis is significantly reduced (n=21; *p<0.05).  (D) The Y27632 effect was  
larger in the presence of LIM kinase 1 (D460A) but this was not significant (n=21; 
p=0.143).
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Figure 15. Cofilin Modulates Kv1.2 Trafficking Downstream of LIM Kinase
Transient transfection of HEK-K cells with increasing amounts of DNA encoding a 
constitutively active form of cofilin (S3A) significantly increases steady-state surface 
Kv1.2 in a concentration-dependent manner as detected by flow cytometry (n=12, 
*p<0.01, **p<0.001).  
0
0.5
1.0
1.5
0 1 2 3
Cofilin S3A (μg)
N
or
m
al
iz
ed
 c
ou
nt
**
*
N
or
m
al
iz
ed
 c
ou
nt
N
or
m
al
iz
ed
 c
ou
nt
 61
AFigure 16. Proposed Model for Kv1.2 Regulation by RhoA/Rho-kinase
(A) LPA activates the RhoA/ROCK/LIM kinase pathway to trigger clathrin-dependent 
Kv1.2 endocytosis.  Dynamin is essential for both steady-state and LPA-induced 
Kv1.2 trafficking. (B) Steady-state Kv1.2 homeostasis is maintained by a balance of 
constitutive, cholesterol-dependent endocytosis and recycling.  Basal RhoA acts 
through ROCK, LIM kinase, and cofilin to control constitutive Kv1.2 recycling.  
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CHAPTER 3: SUPPLEMENTAL DATA AND FUTURE DIRECTIONS 
 
Introduction 
In the previous chapter many questions were answered about how RhoA signaling 
relates to Kv1.2 regulation.  Many additional questions were raised during the course of 
those studies.  This chapter is designed to address some of them and provide new 
directions for continued research into the regulation of cellular excitability by RhoA. 
 Previous studies demonstrated that tyrosine kinase-dependent phosphorylation is 
a potent mechanism of channel suppression (Huang et al., 1993; Holmes et al., 1996).  
For Kv1.2 tyrosine phosphorylation via the M1 muscarinic acetylcholine receptor (M1 
mAChR) was shown to require trans-activation of the EGF receptor tyrosine kinase (Tsai 
et al., 1997).  It was later shown that RhoA activity was necessary downstream of 
carbachol (CCh) stimulation of M1 mAChR for suppression of Kv1.2 ionic current 
(Cachero et al., 1998).  A subsequent study identified endocytosis as a physical 
mechanism for Kv1.2 suppression (Nesti et al., 2004).  What remained was to determine 
if a link exists between RhoA signaling and tyrosine kinase-dependent modulation of 
Kv1.2.  To that end, the contribution of RhoA and ROCK to CCh-induced Kv1.2 
endocytosis was evaluated.   
 Chapter 2 also established a role for basal RhoA/ROCK signaling in the control 
of constitutive outward trafficking of Kv1.2.  We hypothesized this signaling controls 
recycling of constitutively endocytosed channel but another possibility exists; the 
outward trafficking of newly synthesized Kv1.2 from the Golgi apparatus.  In support of 
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this hypothesis Yang and colleagues have shown in kidney epithelial cells that ROCK is 
required for outward trafficking of Na+/H+ antiporter (NHE) from a sub-apical pool to the 
apical cell surface in response to increased pH load (Yang et al., 2007).  In this chapter 
we test this hypothesis; the effect of basal ROCK inhibition on steady-state surface Kv1.2 
was evaluated under conditions of impaired Golgi protein trafficking. 
 The previous chapter also demonstrated that a cholesterol-dependent 
endocytosis pathway is a critical part of steady-state Kv1.2 homeostasis, but did not 
elaborate on the specifics of the pathway beyond its requirement for dynamin.  To 
address this question, chapter 3 includes a more in-depth assessment of the effectiveness 
of the sterol-binding agent filipin to perturb constitutive channel endocytosis and an 
investigation into the contribution of caveolae to constitutive Kv1.2 endocytosis.  Other 
labs have demonstrated that Kv1.5 channels associate with caveolin, that this association 
regulates channel trafficking to cholesterol-rich membrane regions, and that this serves as 
a means to modulate channel function (Martens et al., 2001; McEwen et al., 2008).  
Caveolin-dependent endocytosis has also been shown to require dynamin, therefore it 
was a natural candidate for study (Minshall et al., 2000; Pelkmans et al., 2001; Le et al., 
2002).   
 As mentioned throughout this thesis, RhoA signals through a variety of 
downstream effectors.  Chapter 2 explored how RhoA signals through ROCK to control 
Kv1.2 trafficking without investigating how or if other RhoA effectors may be involved.  
In chapter 3, the contribution of another RhoA effector, protein kinase N, is evaluated.  
Protein kinase N (PKN), like ROCK, is a serine/threonine kinase (Amano et al., 1996b).  
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PKN was an attractive candidate for study here because of work conducted in yeast 
where it was shown to regulate endocytosis via phosphorylation of proteins that come 
together to form an endocytic complex.  Complex formation is inhibited upon PKN-
mediated protein phosphorylation (Cope et al., 1999; Zeng and Cai, 1999; Zeng et al., 
2001), making PKN a negative regulator of endocytosis in yeast.  PKN has also been 
shown to regulate intermediate filament polymerization.  Phosphorylation by PKN 
inhibits polymerization of neurofilamin, vimentin, and glial fibrillary acidic protein 
(GFAP) (Mukai et al., 1996; Matsuzawa et al., 1997).  Phosphorylation of the 
microtubule-associated protein tau by PKN has also been demonstrated, which reduces 
the stabilization and assembly of microtubules, which has important implications for 
neuron function (Taniguchi et al., 2001).  As was done with ROCK, studies in chapter 3 
were designed to assess the role of PKN in both steady-state and stimulus-induced Kv1.2 
trafficking. 
 
Materials and Methods 
Materials 
Rabbit polyclonal antibody directed against the first extracellular loop of Kv1.2 (α-
Kv1.2e) was developed in conjunction with Biosource International (Camarillo, CA).  
GM 130 polyclonal (α-GM 130) antibody was purchased from EMD Biosciences (San 
Diego, CA).  AlexaFluor-conjugated secondary antibodies and phalloidin were purchased 
from Invitrogen (Carlsbad, CA).  Y27632 was purchased from EMD Biosciences (San 
Diego, CA), C3 exoenzyme was purchased from Cytoskeleton Inc. (Denver, CO), 
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HA1077 was purchased from Millipore (Billerica, MA), Lysophosphatidic acid (LPA), 
Carbachol, and Brefeldin A were purchased from Sigma-Aldrich (St. Louis, MO).  
Caveolin-1 (S80E) and PKN (K644E) were generously provided by Dr. J. Pessin (SUNY 
Stony Brook) and Dr. Y. Ono (Kobe University).   
Cell culture and transfection 
 Human embryonic kidney 293 cells stably expressing Kv1.2-α, Kvβ2 and the M1 
muscarinic acetylcholine receptor (HEK-K) were utilized and cultured as previously 
reported (Nesti et al., 2004).  All experimental plasmid constructs were co-transfected 
into HEK-K cells with pEGFP-N1 using calcium phosphate.  Confluent cultures were 
plated to a density of 3.3 x 104 cells per cm2 onto tissue culture plates or glass cover slips 
(Corning Glass Works, Corning, NY) coated with poly-D-lysine (Sigma-Aldrich, St. 
Louis, MO) (0.1 mg/ml) or plasma fibronectin (0.015 mg/ml) for flow cytometry and 
immunofluoresence 12-16 h in serum-free media before use. 
Detection of surface Kv1.2 
 For flow cytometric detection of surface Kv1.2, HEK-K cells were treated with saline, 
vehicle control solution, or an appropriate stimulus, then 154 mM sodium azide as in 
(Nesti et al., 2004).  After azide, the cells were lifted and placed in a test tube where 
surface Kv1.2 was labeled with 0.33 μg/ml α-Kv1.2e.  Antibody binding was detected 
with fluorescently conjugated anti-rabbit IgG (0.1 μg/ml).  Fluorescence was detected by 
flow cytometry as described below.   
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Flow cytometry 
 A single laser flow cytometer (Easy Cyte PCA-96; Guava Technologies, Hayward, CA) 
was used.  In all HEK-K cells, α-Kv1.2e primary antibody was detected by labeling with 
a goat α-rabbit secondary antibody conjugated to PE/CyTM5 with an excitation peak of 
488nm and an emission peak of 667nm (Southern Biotechnology, Birmingham, AL).  
Surface Kv1.2 in transfected cells was taken as the distribution of cells emitting at 667 
nm (indicating surface Kv1.2) in cells also emitting at 508 nm (indicating GFP 
expression).  Background staining was quantitated in cells using goat α-rabbit-PE/CyTM5 
without prior application of α-Kv1.2e. 
Immunofluorescence 
Confluent cultures were plated as for flow cytometry and pre-treated as indicated at 37ºC.  
α-Kv1.2e was applied to live cells at 0.33 μg/ml for 10 min at 37ºC.  Cells were fixed 
with 4% paraformaldehyde (Polysciences, Warrington, PA) in PHEM 6.1 buffer (60 mM 
PIPES, 25 mM HEPES, 2 mM MgCl2, 10 mM EGTA; pH to 6.1 with KOH) at room 
temperature.  Cells were extracted with ice cold acetone.  Coverslips were incubated in 
blocking buffer (PHEM 6.9, 3% goat serum, 0.1% fish skin gelatin) at room temperature.  
Other primary antibodies were then applied (rabbit α-GM 130 = 0.7 μg/ml) diluted in 
blocking buffer.  Alexa Fluor-conjugated secondary antibodies were applied (4 μg/ml in 
blocking buffer) (Invitrogen, Carlsbad, CA) at room temperature.  F-actin was detected 
with Alexa Fluor 488 phalloidin (Invitrogen) (4 U/ml).  Coverslips were mounted on 
glass slides with ProLong Gold mounting medium (Molecular Probes) according to the 
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provided protocol.  Images were obtained with the DeltaVision reconstruction 
microscopy system (Applied Precision).   
Statistical analysis 
Descriptive statistics are provided in figures as line or bar graphs indicating the sample 
mean with error bars indicating the standard error of the mean (SEM).  Detection of 
statistical difference between two independent measurements was by one-way t-test.  
Comparison of percent changes between pairs of independent measurements was by two-
way ANOVA.  Post-hoc power analysis was used to gauge experimental sensitivity and 
sample sizes necessary to achieve 95% power.  Sample populations were considered to be 
significant at p<0.05. 
 
Results 
Tyrosine kinase-dependent Kv1.2 endocytosis requires RhoA and ROCK 
The studies of Kv1.2 in this thesis built from work previously conducted that 
demonstrated the channel is endocytosed and electrophysiologically suppressed 
downstream of tyrosine phosphorylation at specific residues and that phosphorylation 
occurs following M1 mAChR stimulation with CCh (Huang et al., 1993; Hattan et al., 
2002; Nesti et al., 2004).  It was CCh-induced Kv1.2 suppression that was initially 
blocked by inhibiting RhoA using C3 exoenzyme (Cachero et al., 1998).  In chapter 2 we 
used LPA to link RhoA to Kv1.2 endocytosis.  We did not, however, directly test the 
hypothesis that M1 mAChRs also elicit Kv1.2 endocytosis through RhoA.  In this chapter 
we test that hypothesis.   
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 Treatment of HEK-K cells with C3 exoenzyme (0.5 μg/ml, 6 h) elicited a 
significant increase of steady-state surface Kv1.2.  Subsequent stimulation of these cells 
with CCh (10 μM, 10 min) still significantly reduced surface Kv1.2 levels (Figure 1A; 
n=17, *p<0.05, **p<0.001).  The magnitude of the CCh-induced Kv1.2 endocytosis was 
reduced by over 50% in the presence of C3 exoenzyme although this reduction was not 
significant by 2-way ANOVA (Figure 1B; n=17, p=0.23).  Based on the variability of this 
pilot study, a power analysis illustrated that a sample size of over 40 would be required to 
detect a difference in CCh-induced suppression as large the one as shown in Figure 1B 
with 95% confidence (Figure 1C).  Inhibition of ROCK by application of Y27632 (10 
μM, 30 min) also resulted in a significant increase of steady-state surface Kv1.2.  CCh 
stimulation in the presence of Y27632 did not significantly suppress the channel (Figure 
2A, Figure 2B; n=18, *p<0.05, **p<0.001).  Based on the variability of this pilot study, a 
power analysis illustrated that a sample size of over 80 would be required to detect a 
difference in CCh-induced channel suppression as large as the one shown in Figure 2B 
with 95% confidence (Figure 2C).  Although these are only preliminary results, the data 
support the hypothesis that inhibition of RhoA and ROCK reduce CCh-induced Kv1.2 
endocytosis and suggests that RhoA signaling is part of a larger overall network of 
signals that regulate Kv1.2. 
Basal ROCK modulates steady-state Kv1.2 at the plasma membrane 
 The elevation of steady-state surface Kv1.2 by inhibition of basal ROCK can be 
the result of increased recycling of constitutively endocytosed channel, as hypothesized 
in chapter 2, or of increased outward trafficking of newly synthesized Kv1.2 from the 
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Golgi apparatus to the plasma membrane.  To evaluate this possibility HEK-K cells were 
subjected to brefeldin A (BFA) to disrupt the integrity of the Golgi apparatus (Yoo et al., 
2005).  Application of BFA (5 μM, 1 h) disrupted the Golgi apparatus (Figure 3) as 
evidenced by dispersal and more punctate staining of the Golgi marker GM 130 in BFA-
treated cells compared to methanol-treated control.  BFA treatment significantly reduced 
steady-state levels of surface Kv1.2 suggesting that, to some extent, outward trafficking 
of newly synthesized channel does contribute to Kv1.2 homeostasis.  However, despite 
having a compromised Golgi apparatus, application of Y27632 (10μM, 30 min) to BFA-
treated cells still elicits a significant increase of surface Kv1.2 (Figure 4A; n=15, 
*p<0.05, **p<0.01).  The magnitude of the Y27632-induced increase is the same in the 
absence or presence of BFA (Figure 4B; n=15, p=0.54).  This result supports the previous 
hypothesis from chapter 2 that basal ROCK negatively regulates constitutive Kv1.2 
recycling at the plasma membrane independently of constitutive, cholesterol-dependent 
endocytosis. 
Caveolin influences steady-state Kv1.2 homeostasis 
 It has been shown that manipulating membrane cholesterol can modulate the 
distribution and trafficking of other Kv channels such as Kv1.3, Kv1.4, and Kv2.1 
(O'Connell and Tamkun, 2005).  Earlier in this dissertation we demonstrated the essential 
nature of plasma membrane cholesterol for surface expression of Kv1.2 (Chapter 2; 
Figures 11, 12).  This was done, in part, by utilizing the sterol-binding agent filipin to 
disrupt membrane cholesterol.  Figure 5 shows that application of increasing 
concentrations of filipin (1 h) to un-stimulated HEK-K cells elicits a concentration-
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dependent increase of steady-state surface Kv1.2, with a maximal effect occurring 
between 5.0 and 10 μM (n=5, **p<0.001).   
To gain a more complete appreciation of different cholesterol-dependent 
mechanisms through which constitutive endocytosis of Kv1.2 may occur, we chose to 
evaluate the contribution of one well-known route of internalization, namely caveolae.  
To test the idea that caveolin may be important for Kv1.2 trafficking in our system, a 
dominant negative form of caveolin 1, (S80E) was over-expressed.  This point mutation 
has been shown to act as a phospho-mimetic which disrupts caveolae organization and 
subsequent endocytosis (Shigematsu et al., 2003).  Caveolin 1 (S80E) over-expression 
produces a significant increase in steady-state surface Kv1.2, suggesting that some 
caveolin-dependent endocytosis is occurring in our HEK-K cells and is partially 
contributing to overall Kv1.2 homeostasis (Figure 6A; n=24, *p<0.01, **p<0.001).  
Despite the presence of caveolin 1 (S80E), Y27632 treatment (10 μM, 30 min) elicited an 
additional increase in surface Kv1.2 (Figure 6A; n=24, *p<0.01, **p<0.001).  The 
magnitude of the Y27632-induced increase of surface Kv1.2 was elevated by over 50% in 
the presence of caveolin 1 (S80A) (Figure 6B; n=24, p=0.12) but was not significant by 
2-way ANOVA.  Based on the variability of these experiments, a power analysis 
illustrated that a sample size of over 70 would be required to detect a difference in 
Y27632-induced channel elevation as large as the one shown in Figure 6B with 95% 
confidence (Figure 6C).     This result lends additional support to the assertion that basal 
ROCK signaling negatively regulates constitutive Kv1.2 recycling at the plasma 
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membrane independently of constitutive, cholesterol-dependent endocytosis which, this 
data suggests, partially involves caveolae.  
Protein kinase N can control Kv1.2 trafficking downstream of RhoA 
We began investigating protein kinase N (PKN) in our HEK-K cell system using 
pharmacological inhibitors.  As tends to be the case, specific inhibitors are seldom as 
specific as they initially are deemed and experiments have shown that the ROCK 
inhibitor Y27632, which we use extensively throughout our studies, has some ability to 
inhibit PKN.  Another inhibitor, HA1077, is designed to inhibit PKN but has some ability 
to inhibit ROCK (Davies et al., 2000).  When applied separately (10 μM, 30 min) both 
HA1077 and Y27632 significantly increase steady-state surface Kv1.2.  When applied 
together, the individual increases are additive (Figure 7A; n=53; **p<0.001), suggesting 
that ROCK and PKN act in parallel to regulate steady-state surface Kv1.2.  In an 
experiment designed to confirm that the HA1077 effect was specific to PKN, increasing 
amounts of a dominant negative form of PKN that lacks catalytic activity, PKN (K644E), 
were transfected into HEK-K cells.  This resulted in a concentration-dependent increase 
of steady-state surface Kv1.2 (Figure 7B; n=10; **p<0.01), suggesting in conjunction 
with HA1077 data, that PKN is at least partially active in un-stimulated HEK-K cells and 
can modulate steady-state surface Kv1.2.   
  Because of its demonstrated ability to modulate steady-state Kv1.2, we next 
hypothesized that, like ROCK, PKN contributes to LPA-induced, clathrin-dependent 
endocytosis of Kv1.2.  To test this hypothesis, endocytosis of Kv1.2 after LPA 
application (10 μM, 15 min) was measured in the presence or absence of over-expressed 
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PKN (K644E).  Under these conditions PKN (K644E) significantly increased steady-state 
surface Kv1.2, although LPA-induced endocytosis of the channel still occurred (Figure 
8A; n=69, **p<0.001).  The magnitude of the LPA-induced endocytosis is reduced by 
approximately 33% in the presence of dominant negative PKN but was not significant by 
2-way ANOVA (Figure 8B; n=69, p=0.98).  Based on the variability of these 
experiments, a power analysis illustrated that a sample size of over 100 would be 
required to detect a difference in LPA-induced channel endocytosis as large as the one 
shown in Figure 6B with 95% confidence (Figure 8C).  Alternatively, over-expression of 
an active form of PKN, PKN (AF3), which lacks an N-terminal auto-inhibitory domain, 
does not reduce LPA-induced endocytosis of Kv1.2.  Rather, the endocytosis of the 
channel is significantly increased in the presence of over-expressed PKN (AF3) (Figure 
9A, Figure 9B; n=11, *p<0.01, **p<0.001).  Curiously, PKN (AF3) dramatically 
increases steady-state surface Kv1.2 as well (Figure 9A; n=11, **p<0.001).  Taken 
together, these results suggest that PKN can be an important regulator of Kv1.2 
downstream of RhoA and provides the rationale to investigate the potential of RhoA 
effectors other than ROCK to regulate cellular excitability. 
 
 
Discussion 
 Regulation of cellular excitability is a complex process that involves many 
overlapping networks of signals.  In this chapter we performed experiments designed to 
answer specific questions about how RhoA mediates cellular excitability by controlling 
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Kv1.2 trafficking.  We also began exploring avenues of RhoA downstream signaling that 
were not touched upon in chapter 2 of this thesis.   
We previously demonstrated that Kv1.2 undergoes both steady-state and acute 
forms of regulation that involve independent trafficking pathways, both with a 
requirement for RhoA/ROCK.  Following those experiments, we became interested in 
another RhoA downstream effector, protein kinase N (PKN) based on the results of a 
study that indicated certain ROCK inhibitors, like Y27632, also have some ability to 
inhibit PKN (Davies et al., 2000).  In Figure 7A we show that application of the PKN 
inhibitor HA1077 elicits a significant increase of steady-state surface Kv1.2, similar to 
that obtained by the application of Y27632.  Concurrent application of the two inhibitors 
results in an even larger increase of surface Kv1.2, suggesting that both ROCK and PKN 
can modulate steady-state surface Kv1.2.  Over-expression of increasing amounts of 
DNA encoding dominant negative PKN (K644E) results in a concentration-dependent 
increase of steady-state surface Kv1.2 (Figure 7B) further suggesting that PKN alone has 
the ability to modulate Kv1.2 trafficking.  These data suggest the possibility that PKN, 
like ROCK can modulate the recycling phase of steady-state Kv1.2 homeostasis.  To 
more fully explore how PKN can modulate steady-state Kv1.2, future studies using the 
HA1077 inhibitor can be conducted.  This includes time-course and dose-response 
studies, in conjunction with Y27632 to ascertain the maximal results these 
pharmacological agents can elicit and if their effects truly are independent.  Other studies 
utilizing low temperature in conjunction with HA1077 and PKN (K644E) over-
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expression can more fully answer these questions as well by separating constitutive 
endocytosis from constitutive recycling. 
 That PKN modulates Kv1.2 trafficking is not surprising as PKN has been 
previously reported to control the kinetics of intracellular EGF receptor trafficking 
(Gampel et al., 1999).  Indeed, a role for PKN has emerged through studies in yeast that 
demonstrate a requirement for PKN in maintaining dynamic actin polymerization in 
concert with the Arp2/3 complex, allowing for proper vesicle internalization and 
subsequent trafficking (Duncan and Payne, 2005).  Specifically, PKN in yeast has been 
shown to phosphorylate and inhibit Pan1p, a protein that is instrumental for recruiting 
endocytic proteins like clathrin to sites of internalization (Huang et al., 2003).  Moreover, 
Pan1p can bind F-actin and activate the Arp2/3 complex (Toshima et al., 2005), 
characteristics very similar to those of cortactin, a protein previously reported to be 
required for proper steady-state and acute Kv1.2 regulation (Hattan et al., 2002; Williams 
et al., 2007).  This sets up the intriguing possibility that PKN can negatively regulate 
proteins that directly couple the actin cytoskeleton to sites of endocytosis.        
In Figures 8 and 9, we show that PKN can also affect acute trafficking of Kv1.2.  
Over-expression of dominant negative (K644E) and active (AF3) forms of PKN have 
opposing effects on LPA-induced endocytosis of Kv1.2.  There is a significant increase 
of both steady-state surface Kv1.2 and LPA-induced channel endocytosis in the presence 
of active PKN.  Since PKN functions as a negative regulator of endocytic protein 
recruitment (Huang et al., 2003; Duncan and Payne, 2005; Toshima et al., 2005) it seems 
reasonable to posit that active PKN should perturb constitutive endocytosis and elevate 
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steady-state surface Kv1.2.  This assertion suggests that PKN can modulate the 
internalization phase of Kv1.2 homeostasis, perhaps also explaining the additive effects 
of treating HEK-K cells with Y27632 and HA1077.  We were surprised however, by the 
enhanced LPA-induced Kv1.2 endocytosis in the presence of PKN (AF3), as this result 
seems to contradict what the literature says about PKN endocytic function.  Caution must 
be exercised when interpreting the results of over-expressing PKN proteins as dominant 
negative PKN over-expression has been shown to perturb other signaling pathways 
downstream of RhoA (Gampel et al., 1999). Therefore the effects of PKN (K644E) or 
(AF3) on LPA-induced Kv1.2 endocytosis may not be totally accurate.  An additional 
series of experiments that could prove very informative again utilize low temperature, as 
was done in chapter 2, to more fully explore whether over-expressing PKN (K644E) or 
(AF3) modulates constitutive Kv1.2 endocytosis, recycling, or if the effects in Figures 8 
and 9 are an over-expression phenomenon.   
In the previous chapter we demonstrated that constitutive, cholesterol-dependent 
steady-state Kv1.2 homeostasis could be effectively separated from acute, clathrin-
dependent Kv1.2 endocytosis.  Furthermore, we demonstrated that for steady-state Kv1.2 
homeostasis, the cholesterol-dependent internalization phase and the recycling phase can 
be manipulated independently from one another.  Our previous conclusion regarding the 
role of RhoA/ROCK in steady-state Kv1.2 homeostasis was that ROCK functions as a 
negative regulator of the recycling phase.  We confirm this conclusion by answering a 
new question; does ROCK modulate delivery of newly synthesized Kv1.2 to the cell 
surface?  Using brefeldin A (BFA) to disrupt the Golgi apparatus (Figure 3) (Yoo et al., 
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2005) had no effect on the ability of ROCK inhibition to elicit a significant increase of 
surface Kv1.2 despite the fact that BFA lowered the initial steady-state level of channel at 
the cell surface (Figure 4).  These results are interesting, especially when combined with 
those obtained in a study that reported the opposite effect of cyclic-AMP signaling on 
steady-state homeostasis of Kv1.2 (Connors et al., 2008).  In this report, it was increased 
cyclic-AMP signaling led to elevated levels of surface Kv1.2, suggesting that ROCK and 
cyclic-AMP work from opposite ends to coordinately regulate steady-state Kv1.2 
homeostasis.  This would not be a surprising occurrence as it has been demonstrated that 
activation of protein kinase A (PKA) downstream of cyclic-AMP can negatively regulate 
RhoA and ROCK signaling (Dong et al., 1998; Forget et al., 2002).   
In Figure 6 we show that over-expression of a dominant negative caveolin 1 
(S80E) has an effect on steady-state Kv1.2 homeostasis.  This resulted in increased 
steady-state surface Kv1.2.  In the presence of caveolin 1 (S80E), the Y27632-induced 
surface Kv1.2 increase trended toward being elevated.  It is important to note that the 
results shown in Figure 6 represent the outcome of an initial pilot study.  With that in 
mind, a power analysis on these preliminary results was performed with the goal of 
estimating the sample size needed to detect changes in the Y27632-mediated elevation of 
surface Kv1.2 with 95% confidence.  Caveolae are known to be involved in the 
regulation of other Shaker family channels such as Kv1.3 and Kv1.5 (Martens et al., 
2001; Eldstrom et al., 2006; Vicente et al., 2008) so their involvement with Kv1.2 is not 
unexpected.  It is notable, however, that Kv1.3 and Kv1.5 are not exclusively found in 
caveolae (Martinez-Marmol et al., 2008).  Based on the results in Figure 6, the same 
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could be said for Kv1.2 because the effects of caveolin-1 (S80E) over-expression are not 
nearly as pronounced as those of filipin treatment, suggesting that steady-state Kv1.2 
homeostasis is cholesterol- but not necessarily caveolae-dependent.  To pursue the 
involvement of caveolae further, one could also apply filipin to cells over-expressing 
caveolin 1 (S80E).  If caveolae are partially involved in Kv1.2 homeostasis, one would 
not expect caveolin 1 (S80E) to elicit an additional increase of surface channel beyond 
filipin treatment alone.  In addition, the ability of Kv1.2 to undergo clathrin-dependent 
endocytosis supports the existence of pools of Kv1.2 that do not necessarily reside in 
relatively cholesterol-rich regions of the plasma membrane.  A recent study has 
implicated caveolin 1 as a regulator of Rho/ROCK activity in fibroblasts (Grande-Garcia 
et al., 2007).  This report goes on to say that in the absence of caveolin 1, Src kinase 
activity is increased, which then can elevate p190RhoGAP activity resulting in reduced 
RhoA/ROCK signaling (Grande-Garcia et al., 2007).  These data could potentially 
explain the increased Y27632 effect obtained in the presence of caveolin 1 (S80E) 
(Figure 6).  Putting these results into the larger context of Kv1.2 regulation sets up the 
possibility that caveolin 1 may be involved in both the constitutive, cholesterol-dependent 
internalization phase and the RhoA/ROCK sensitive recycling phase of steady-state 
Kv1.2 homeostasis. 
We also report that RhoA/ROCK is involved in Kv1.2 endocytosis triggered by 
stimulation of the M1 muscarinic acetylcholine receptor (M1 mAChR) with carbachol 
(CCh).  It was through M1 mAChR signaling that endocytosis of Kv1.2 was first 
demonstrated (Nesti et al., 2004).  Inhibition of RhoA activity with C3 exoenzyme led to 
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reduced Kv1.2 endocytosis in the presence of CCh (Figure 1) as did inhibition of ROCK 
activity with Y27632 (Figure 2).  Importantly, both application of C3 exoenzyme and 
Y27632 also resulted in significant increases of steady-state surface Kv1.2, as was 
demonstrated in chapter 2.  These findings indicate that RhoA/ROCK modulates Kv1.2 
trafficking downstream of multiple G protein-coupled receptors, not just those activated 
by LPA.  It is known however, that both LPA and M1 mACh receptors can signal via 
G12/13 to activate RhoA (Moolenaar, 1995; Fromm et al., 1997; Bian et al., 2006).  We 
also note that C3 exoenzyme blockade of CCh-induced endocytosis is not complete.  This 
could result from CCh triggering parallel pathways to modulate Kv1.2, only one of which 
involves RhoA (Tsai et al., 1997).  Alternatively, inhibition of RhoA by C3 exoenzyme 
may not have been complete under the experimental conditions used.  We view the latter 
as more likely since inhibition of ROCK with Y27632 did not allow for significant CCh-
induced channel endocytosis (Figure 2).  Importantly, the results shown in Figures 1 and 
2 represent the outcomes of initial pilot studies.  We conducted power analyses using 
these preliminary results to estimate the sample size needed to detect changes in CCh-
induced Kv1.2 endocytosis with 95% confidence.  These results begin to put RhoA 
signaling into the context of a larger body of research that has shown modulation of 
Kv1.2 function occurs through tyrosine kinase-dependent trafficking of the channel that 
relies on signals impinging on the actin cytoskeleton (Huang et al., 1993; Hattan et al., 
2002; Nesti et al., 2004; Williams et al., 2007). 
Because regulation of cellular excitability is critical for proper cardiovascular and 
neuronal function, there will necessarily be a complex network of signals whose 
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combined effects intricately modulate excitability in those systems.  This work has 
successfully elucidated how RhoA and its downstream effectors can modulate cellular 
excitability by controlling the steady-state homeostasis and acute trafficking of Kv1.2.  
The experiments presented in chapter 3 of this thesis are significant because they confirm 
and strengthen assertions made in chapter 2, such as that basal ROCK activity modulates 
the recycling phase of steady-state Kv1.2 homeostasis.  They also investigate the 
involvement of more specific or alternative signaling components in the overall scheme 
of RhoA-mediated Kv1.2 trafficking, broadening our understanding of the redundancy 
and interconnectedness of the mechanisms through which cellular excitability is 
regulated.   
The investigations in chapters two and three of this thesis were carried out in a 
model cell system (HEK-K cells) that is amenable to various forms of cellular and 
biochemical analysis.  Utilization of this model system was crucial because the results 
thereby derived form the basis of future studies investigating Kv1.2 trafficking and 
regulation in a more physiological setting.  An example of such a setting is neurons of the 
central nervous system. 
 Hippocampal neurons are of particular interest because Kv1.2 is heavily 
endogenously expressed there (Tsaur et al., 1992; Sheng et al., 1994; Veh et al., 1995; 
Grosse et al., 2000).  Kv1.2 localizes predominantly to the dendrites of the hilar and 
pyramidal neurons of the CA3 and CA1 regions with very little channel present in the 
cell bodies of these neurons (Sheng et al., 1994).  There is also significant Kv1.2 
localization in the molecular layer of the dentate gyrus which, studies have shown, 
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overlaps with Kv1.4 potentially indicating the presence of heteromeric Kv1 channels 
there (Sheng et al., 1992; Sheng et al., 1993).   
The hippocampus is also amenable to many different types of experimentation 
including neuron dissociation and culture, slice culture, electrophysiology, 
immunocytochemistry, and biochemical analyses.  Indeed, it has been shown that the 
developmental timecourse of Kv1 channel expression in hippocampal cultures is very 
similar to that of the intact tissue (Grosse et al., 2000), supporting the use of ex-vivo 
hippocampal cultures for studying ion channel regulation.  Additionally, it has been 
shown that long-term potentiation, a model for learning and memory, can be elicited in 
the hippocampus via muscarinic acetylcholine receptor stimulation.  This G protein-
coupled receptor activation correlates to increased responsiveness of these neurons to 
afferent stimulation along with increased activity of tyrosine and serine/threonine kinases 
(Segal and Auerbach, 1997).  This, coupled with the knowledge that Kv1.2 ionic current 
is suppressed in a tyrosine phosphorylation-dependent manner downstream of muscarinic 
G protein-coupled receptor stimulation (Huang et al., 1993) makes investigating the 
RhoA/ROCK-dependent trafficking of Kv1.2 in the hippocampus all the more interesting. 
 RhoA/ROCK has already been implicated in long-term spatial memory.  Studies 
by Dash and colleagues have shown that intra-hippocampal infusion of LPA to activate 
RhoA in live rats leads to enhanced performance in behavioral tests designed to measure 
formation of long-term spatial memory.  Additionally, intra-hippocampal infusion of the 
ROCK inhibitor Y27632 impairs long-term spatial memory (Dash et al., 2004).  Given 
our conclusions about RhoA/ROCK-mediated Kv1.2 trafficking in HEK-K cells, the 
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results of Dash and colleagues suggest that RhoA/ROCK-mediated memory formation in 
the hippocampus may be the result, at least in part, of altered ion channel trafficking.  
Conducting a series of imaging experiments on the hippocampi of rats in the presence of 
LPA or Y27632 would allow us to assess the relative levels of surface Kv1.2 and 
electrophysiological measurements on the same tissues would allow for a determination 
of celluar excitability.  We expect there to be less surface Kv1.2 and enhanced cellular 
excitability (reduced Kv1.2 current) in the presence of LPA and greater surface Kv1.2 
and reduced cellular excitability (increased Kv1.2 current) in the presence of Y27632 
commensurate with our data indicating that RhoA activation elicits Kv1.2 endocytosis 
and inhibition of basal ROCK relieves downregulation of constitutive channel recycling 
to the plasma membrane. 
 Downstream of ROCK, we implicated LIM kinase (LIMK) as a crucial 
component regulating Kv1.2 trafficking.  It too has been implicated in hippocampal 
function.  LIMK1 null mice have dramatically altered hippocampal dendritic spine 
morphology as well as impaired spatial learning and enhanced long-term potentiation 
(Meng et al., 2002).  This correlated to a reduction of phosphorylated cofilin and an 
overall reduction of synapse surface area (Meng et al., 2002).  It is in the dendrites of 
hippocampal neurons that Kv1.2 can be found (Sheng et al., 1994),  therefore it seems 
reasonable to hypothesize that these physiological LIMK-mediated effects would impact 
the function of Kv1.2 there.    Based on our HEK-K cell results, we expect the absence of 
LIMK1 to increase the levels of surface Kv1.2 as LIMK appears to function downstream 
of ROCK as a negative regulator of constitutive Kv1.2 recycling.  However, LIMK1 null 
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mice also have reduced synapse surface area which would seem to limit the space 
available for Kv1.2 channels to modulate synaptic transmission.  Therefore, application 
of LIMK RNAi or anti-sense oligonucleotides via microinjection or permeabilization of 
hippocampal slices may be a more suitable technique for investigating the role of LIMK 
in Kv1.2 trafficking in neurons.  A combination of imaging and electrophysiology studies 
will shed light on the localization and function of Kv1.2 under conditions of altered 
LIMK signaling. 
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Figure 1. Effect of RhoA Inhibition on Carbachol-induced Kv1.2 Endocytosis
(A) Pre-treatment of HEK-K cells with C3 exoenzyme (0.5 μg/ml, 6 h) increases 
steady-state surface Kv1.2 and reduces CCh-induced Kv1.2 endocytosis as detected 
by flow cytometry (n=17, *p<0.05, **p<0.001).  (B) The trend is toward reduced 
CCh-induced endocytosis of Kv1.2 in the presence of C3 exoenzyme but the reduction 
is not significant (n=17, p=0.23).  (C) This experiment has approximately 67% power 
to detect a difference in CCh-induced Kv1.2 endocytosis as large as the one shown in 
(B).  Based on this analysis, a sample size of over 40 is necessary to achieve 95% 
power.
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Figure 2. Effect of ROCK Inhibition on Carbachol-induced Kv1.2 Endocytosis
(A) Application of Y27632 (10 μM, 30 min) significantly increases steady-state 
surface Kv1.2 and reduces CCh-induced Kv1.2 endocytosis as detected by flow 
cytometry (n=18; *p<0.05, **p<0.001).  (B) The trend is toward reduced CCh-
induced endocytosis of Kv1.2 in the presence of Y27632 but the reduction is not 
significant (n=18, p=0.74).  (C) This experiment has approximately 42% power to 
detect a difference in CCh-induced Kv1.2 endocytosis as large as the one shown in 
(B). Based on this analysis, a sample size of over 80 is necessary to achieve 95% 
power.
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Figure 3. Brefeldin A Disrupts the Golgi Apparatus in HEK-K Cells
Application of brefeldin A (5µM, 1 h) redistributes staining of the Golgi marker GM 
130 into a more punctate distribution compared to to methanol control (red).  GM 130 
was labeled with a rabbit polyclonal antibody.  Actin (green) was labeled with 
phalloidin.
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Figure 4. ROCK Negatively Regulates Constitutive Kv1.2 Recycling
(A) Pre-treatment of HEK-K cells with brefeldin A (5 μM, 1 h) significantly reduces 
steady-state levels of surface Kv1.2 but does not prevent Y27632 (10 μM, 30 min) 
from eliciting a significant increase of surface Kv1.2 as detected by flow cytometry
(n=15; *p<0.05, **p<0.01).  (B) The Y27632-induced increase of surface Kv1.2 in the 
absence or presence of brefeldin A is not significantly different (n=15; p=0.54).
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Figure 5. Filipin Dose-response Experiment
Application of increasing concentrations of the sterol-binding agent filipin (1 h) to un-
stimulated HEK-K cells results in increased levels of steady-state surface Kv1.2 as 
detected by flow cytometry (n=5, **p<0.001). 
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Figure 6. Caveolin Influences Steady-state Kv1.2 Homeostasis
(A) Over-expression of a dominant negative form of caveolin 1 (S80E) elicits a 
significant increase of steady-state surface Kv1.2.  Application of Y27632 (10µM, 30 
min) in the absence or presence of caveolin 1 (S80E) elicits a significant increase of 
surface Kv1.2 as detected by flow cytometry (n=24; *p<0.01, **p<0.001).  (B) The 
trend is toward an enhanced Y27632 effect in the presence of caveolin 1 (S80E) but 
the increase is not significant (n=24, p=0.12).  (C) This experiment has approximately 
56% power to detect a difference in the Y27632 effect as large as the one shown in 
(B). Based on this analysis, a sample size of over 70 is necessary to achieve 95% 
power.
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Figure 7. Protein Kinase N Modulates Steady-state Kv1.2 Homeostasis Downstream 
of RhoA
(A) Application of the PKN inhibitor HA1077 (10 μM, 30 min) to HEK-K cells 
significantly increases steady-state surface Kv1.2 independent of the effects of the 
ROCK inhibitor Y27632 (10 μM, 30 min) as detected by flow cytometry (n=53; 
**p<0.001).  (B) Transient transfection of increasing amounts of DNA encoding a 
dominant negative form of PKN (K644E) significantly increases steady-state surface 
Kv1.2 in a concentration-dependent manner (n=10; **p<0.01). 
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Figure 8. Effect of Dominant Negative Protein Kinase N on LPA-induced Kv1.2 
Endocytosis 
(A) Over-expression of dominant negative PKN (K644E) in HEK-K cells reveals 
significantly increased steady-state surface Kv1.2 although LPA-induced endocytosis 
still occurs as detected by flow cytometry (n=69; **p<0.001).  (B) The trend is toward 
reduced LPA-induced endocytosis of Kv1.2 in the presence of PKN (K644E) but the 
reduction is not significant (n=69; p=0.98).  (C) This experiment has approximately 
83% power to detect a difference in LPA-induced Kv1.2 endocytosis as large as the 
one shown in (B).  Based on this analysis, a sample size of over 100 is necessary to 
achieve 95% power.
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Figure 9. Active Protein Kinase-N Enhances LPA-induced Kv1.2 Endocytosis
(A) Over-expression of constitutively active PKN (AF3) in HEK-K cells results in 
significantly higher levels of steady-state surface Kv1.2 with LPA-induced Kv1.2 
endocytosis occuring regardless of PKN (AF3) over-expression (n=11; *p<0.01, 
**p<0.001).  (B) LPA-induced Kv1.2 endocytosis is significantly increased in the 
presence of PKN (AF3) (n=11; **p<0.001).
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